<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Modafinil</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Modafinil">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Modafinil</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Modafinil</b>, sold under the brand name <b>Provigil</b> among others, is a medication to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.<span class="mw-ref" id="cite_ref-AHSF2018_1-2"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-FDA2015_7-0"><a href="#cite_note-FDA2015-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> While it has seen off-label use as a purported cognitive enhancer, the research  on its effectiveness for this use is not conclusive.<span class="mw-ref" id="cite_ref-Battleday2015_8-0"><a href="#cite_note-Battleday2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHSF2018_1-3"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>



<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Modafinil</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Modafinil.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Modafinil.svg.png" data-file-width="512" data-file-height="377" data-file-type="drawing" height="136" width="185"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Provigil, Alertec, Modavigil, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>CRL-40476; Diphenylmethylsulfinylacetamide</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/modafinil.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/modafinil.html'" tppabs="https://www.drugs.com/monograph/modafinil.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a602016.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a602016.html'" tppabs="https://medlineplus.gov/druginfo/meds/a602016.html" class="external text external">a602016</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Modafinil&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Modafinil&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Modafinil&SearchType=BasicSearch" class="external text external">Modafinil</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>C (Risk not ruled out)<span> </span><span class="mw-ref" id="cite_ref-AHSF2018_1-0"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Dependence<br>liability</th><td>Relatively low</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Addiction<br>liability</th><td>Very low to low<span class="mw-ref" id="cite_ref-Addiction_liability_review_2-0"><a href="#cite_note-Addiction_liability_review-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Rare_case_of_modafinil_dependence_3-0"><a href="#cite_note-Rare_case_of_modafinil_dependence-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (tablets)<span class="mw-ref" id="cite_ref-AHSF2018_1-1"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N06BA07<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N06BA07  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N06BA07'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N06BA07" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>Schedule IV<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>Not determined due to the aqueous insolubility</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>62.3%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hepatic (primarily via amide hydrolysis;<span class="mw-ref" id="cite_ref-RobertsonHellriegel2003_4-0"><a href="#cite_note-RobertsonHellriegel2003-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5 involved <span class="mw-ref" id="cite_ref-pmid10820139_5-0"><a href="#cite_note-pmid10820139-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>15 hours (<i>R</i>-enantiomer),<br>4 hours (<i>S</i>-enantiomer)<span class="mw-ref" id="cite_ref-nuvigil.com_6-0"><a href="#cite_note-nuvigil.com-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (80%)</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">2-(diphenylmethanesulfinyl)acetamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=68693-11-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=68693-11-8'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=68693-11-8" class="external text external">68693-11-8</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/4236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/4236'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/4236" class="external text external">4236</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7555  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7555'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7555" class="external text external">7555</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00745'" tppabs="https://www.drugbank.ca/drugs/DB00745" class="external text external">DB00745</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4088.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4088.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4088.html" class="external text external">4088</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=R3UK8X3U3D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=R3UK8X3U3D'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=R3UK8X3U3D" class="external text external">R3UK8X3U3D</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01832  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01832'" tppabs="https://www.kegg.jp/entry/D01832" class="external text external">D01832</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31859  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31859'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31859" class="external text external">CHEBI:31859</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1373  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1373'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1373" class="external text external">ChEMBL1373</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0023329  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0023329'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0023329" class="external text external">DTXSID0023329</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.168.719  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.168.719'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.168.719" class="external text external">100.168.719</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>15</sub><span>H</span><sub>15</sub><span>N</span><span>O</span><sub>2</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">273.35</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28C%28c1ccccc1%29c2ccccc2%29CC%28%3DO%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28C%28c1ccccc1%29c2ccccc2%29CC%28%3DO%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DS%28C%28c1ccccc1%29c2ccccc2%29CC%28%3DO%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=S(C(c1ccccc1)c2ccccc2)CC(=O)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:YFGHCGITMMYXAQ-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=800497129&page2=Modafinil  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=800497129&page2=Modafinil'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=800497129&page2=Modafinil" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include headache, anxiety, trouble sleeping, and nausea.<span class="mw-ref" id="cite_ref-AHSF2018_1-4"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Serious side effects may include allergic reactions such as anaphylaxis, Stevens–Johnson syndrome, misuse, and hallucinations.<span class="mw-ref" id="cite_ref-AHSF2018_1-5"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is unclear if use during pregnancy is safe.<span class="mw-ref" id="cite_ref-AHSF2018_1-6"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The amount of medication used may need to be adjusted in those with kidney or liver problems.<span class="mw-ref" id="cite_ref-AHSF2018_1-7"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is not recommended in those with an arrhythmia, significant hypertension, or left ventricular hypertrophy.<span class="mw-ref" id="cite_ref-BNF74_10-0"><a href="#cite_note-BNF74-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> How it works is not entirely clear.<span class="mw-ref" id="cite_ref-AHSF2018_1-8"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> One possibility is that it may affect the areas of the brain involved with the sleep cycle.<span class="mw-ref" id="cite_ref-AHSF2018_1-9"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Modafinil was approved for medical use in the United States in 1998.<span class="mw-ref" id="cite_ref-FDA2015_7-1"><a href="#cite_note-FDA2015-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In the United States it is classified as a schedule IV controlled substance.<span class="mw-ref" id="cite_ref-AHSF2018_1-10"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> In the United Kingdom it is a prescription only medication.<span class="mw-ref" id="cite_ref-BNF74_10-1"><a href="#cite_note-BNF74-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-BNF74_10-2"><a href="#cite_note-BNF74-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Uses">Uses</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Modalert.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Modalert.jpg" data-file-width="4608" data-file-height="3456" data-file-type="bitmap" height="165" width="220"><div class="thumbcaption" style="text-align: left">Modafinil tablets – Modalert 200</div></div></div>

<p>In 2017, modafinil was the 328th most commonly prescribed medication in the United States, with more than 900 thousand prescriptions.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> In the United Kingdom it costs the NHS about £105.21 a month as of 2018.<span class="mw-ref" id="cite_ref-BNF74_10-3"><a href="#cite_note-BNF74-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In the United States the wholesale cost per month is about US$34.20 as of 2018.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p> 


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Medical">Medical</h3></summary>
    
<p>Modafinil is a eugeroic used for treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea.<span class="mw-ref" id="cite_ref-FDA2015_7-2"><a href="#cite_note-FDA2015-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Battleday2015_8-1"><a href="#cite_note-Battleday2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-SleepAcademy2007_13-0"><a href="#cite_note-SleepAcademy2007-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-pmid23385698_14-0"><a href="#cite_note-pmid23385698-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>For obstructive sleep apnea, it is recommended that continuous positive airway pressure be appropriately used before considering starting modafinil to help with daytime sleepiness.<span class="mw-ref" id="cite_ref-AHSF2018_1-11"><a href="#cite_note-AHSF2018-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>Because of the risk for development of skin or hypersensitivity reactions and serious adverse psychiatric reactions, the European Medicines Agency has recommended that new patient prescriptions should be only to treat sleepiness associated with narcolepsy.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Occupational_use">Occupational use</h3></summary>
    

<p>Armed forces of several countries, including the United States, the United Kingdom, India and France, have expressed interest in modafinil as an alternative to <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>—the drug traditionally employed in combat situations or lengthy missions where troops face sleep deprivation. The French government indicated that the Foreign Legion used modafinil during certain covert operations.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The United Kingdom's Ministry of Defence commissioned research into modafinil<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> from QinetiQ and spent £300,000 on one investigation.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In 2011, the Indian Air Force announced that modafinil was included in contingency plans.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>In the United States military, modafinil has been approved for use on certain Air Force missions, and it is being investigated for other uses.<span class="mw-ref" id="cite_ref-urlwww.dtic.mil_20-0"><a href="#cite_note-urlwww.dtic.mil-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> As of November 2012, modafinil is the only drug approved by the Air Force as a "go pill" for fatigue management (replacing prior use of amphetamine-based medications such as <a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">dextroamphetamine</a>).<span class="mw-ref" id="cite_ref-AF48_21-0"><a href="#cite_note-AF48-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>The Canadian Medical Association Journal also reports that modafinil is used by astronauts on long-term missions aboard the International Space Station. Modafinil is "available to crew to optimize performance while fatigued" and helps with the disruptions in circadian rhythms and with the reduced quality of sleep astronauts experience.<span class="mw-ref" id="cite_ref-pmid19487390_22-0"><a href="#cite_note-pmid19487390-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects_and_contraindications">Adverse effects and contraindications</h2></summary>
    
<p>Modafinil is contraindicated in people with known hypersensitivity to modafinil, armodafinil, or inactive ingredients.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Modafinil is not approved for use in children for any medical conditions.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>The incidence of adverse effects are reported as the following: less than 10% of users report having a headache, nausea, and decreased appetite. Between 5% to 10% of users may be affected with anxiety, insomnia, dizziness, diarrhea, and rhinitis.<span class="mw-ref" id="cite_ref-Modafinilstatpearls_25-0"><a href="#cite_note-Modafinilstatpearls-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>Rare occurrences have been reported of more serious adverse effects, including severe skin rashes and other symptoms that are probably allergy-related. From the date of initial marketing, December 1998, to January 30, 2007, the US Food and Drug Administration received six cases of severe cutaneous adverse reactions associated with modafinil, including erythema multiforme (EM), Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and DRESS syndrome, involving adult and pediatric patients. The FDA issued a relevant alert. In the same alert, the FDA also noted that angioedema and multi-organ hypersensitivity reactions have also been reported in postmarketing experiences.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> In 2007, the FDA ordered Cephalon to modify the Provigil leaflet in bold-face print of several serious and potentially fatal conditions attributed to modafinil use, including TEN, DRESS syndrome, and SJS.</p>

<p>The long term safety and effectiveness of modafinil have not been determined.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Modafinil may have an adverse effect on hormonal contraceptives for up to a month after discontinuation.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Addiction_and_dependence">Addiction and dependence</h3></summary>
    
<p>The addiction and dependence liabilities of modafinil are relatively low.<span class="mw-ref" id="cite_ref-Addiction_liability_review_2-1"><a href="#cite_note-Addiction_liability_review-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Modafinil_29-0"><a href="#cite_note-Modafinil-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> It shares biochemical mechanisms with addictive stimulant drugs, and some studies have reported it to have similar mood-elevating properties, although to a lesser degree.<span class="mw-ref" id="cite_ref-Modafinil_29-1"><a href="#cite_note-Modafinil-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>Monkeys will self-administer modafinil if they have previously been trained to self-administer cocaine.<span class="mw-ref" id="cite_ref-Modafinil_29-2"><a href="#cite_note-Modafinil-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> As such, modafinil is classified by the United States FDA as a schedule IV controlled substance, a category for drugs with valid medical uses and low but significant addiction potential.<span class="mw-ref" id="cite_ref-Addiction_liability_review_2-2"><a href="#cite_note-Addiction_liability_review-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Ballon_30-0"><a href="#cite_note-Ballon-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Tolerance">Tolerance</h3></summary>
    
<p>Large-scale clinical studies have found no evidence of tolerance with modafinil at therapeutic dosages even with prolonged use (for 40 weeks and as long as three years).<span class="mw-ref" id="cite_ref-pmid16737742_31-0"><a href="#cite_note-pmid16737742-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid10828434_32-0"><a href="#cite_note-pmid10828434-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid9450772_33-0"><a href="#cite_note-pmid9450772-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Psychiatric_reactions">Psychiatric reactions</h3></summary>
    
<p>Modafinil-associated psychiatric reactions have occurred in those with and without a pre-existing psychiatric history.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>In mice and rats, the median lethal dose (LD<sub>50</sub>) of modafinil is approximately or slightly greater than 1250<span>&nbsp;</span>mg/kg. Oral LD<sub>50</sub> values reported for rats range from 1000–3400<span>&nbsp;</span>mg/kg. Intravenous LD<sub>50</sub> for dogs is 300<span>&nbsp;</span>mg/kg. Clinical trials on humans involving taking up to 1200<span>&nbsp;</span>mg/day for 7–21<span>&nbsp;</span>days and known incidents of acute one-time overdoses up to 4500<span>&nbsp;</span>mg did not appear to cause life-threatening effects, although a number of adverse experiences were observed, including excitation or agitation, insomnia, anxiety, irritability, aggressiveness, confusion, nervousness, tremor, palpitations, sleep disturbances, nausea, and diarrhea.<span class="mw-ref" id="cite_ref-FDA2015_7-3"><a href="#cite_note-FDA2015-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> As of 2004, the FDA is not aware of any fatal overdoses involving modafinil alone (as opposed to multiple drugs including modafinil).<span class="mw-ref" id="cite_ref-FDA2015_7-4"><a href="#cite_note-FDA2015-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    

<p>Coadministration with modafinil alongside opioids such as <a href="Hydrocodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="Oxycodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxycodone" title="Oxycodone">oxycodone</a>, and <a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">fentanyl</a>, as well as various other drugs, may experience a drop in plasma concentrations. The reason behind this action is because modafinil is an inducer of the CYP3A4 enzymes. If not monitored closely, reduced efficacy or withdrawal symptoms can occur.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    

<table class="wikitable floatright">
<caption>Binding profile<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></caption>
<tbody><tr>
<th>Site</th><th>K<sub>i</sub> (nM)</th></tr>
<tr>
<td><abbr>DAT</abbr></td><td>2,600</td></tr>
<tr>
<td><abbr>NET</abbr></td><td>&gt;10,000</td></tr>
<tr>
<td>SERT</td><td>&gt;10,000</td></tr>
</tbody></table>

<p><span>As of 2017</span><span>,</span> the therapeutic mechanism of action of modafinil for narcolepsy and sleep-wake disorders remains unknown.<span class="mw-ref" id="cite_ref-Stahl's_Essential_Psychopharmacology_-_Modafinil_36-0"><a href="#cite_note-Stahl's_Essential_Psychopharmacology_-_Modafinil-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-pmid19300566_37-0"><a href="#cite_note-pmid19300566-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Modafinil acts as an atypical, selective, and weak dopamine reuptake inhibitor which indirectly activates the release of orexin neuropeptides and <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> from the lateral hypothalamus and tuberomammillary nucleus, respectively all of which may contribute to heightened arousal.<span class="mw-ref" id="cite_ref-Stahl's_Essential_Psychopharmacology_-_Modafinil_36-1"><a href="#cite_note-Stahl's_Essential_Psychopharmacology_-_Modafinil-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-pmid19300566_37-1"><a href="#cite_note-pmid19300566-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-pmid22640618_38-0"><a href="#cite_note-pmid22640618-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Dopamine_transporter_blocker">Dopamine transporter blocker</h4></summary>
    

<p>Research found that modafinil elevates <a href="Histamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Histamine" title="Histamine">histamine</a> levels in the hypothalamus in animals.<span class="mw-ref" id="cite_ref-IshizukaMurakami2008_39-0"><a href="#cite_note-IshizukaMurakami2008-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> The locus of the monoamine action of modafinil was also the target of studies, with effects identified on <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a> in the striatum and, in particular, nucleus accumbens,<span class="mw-ref" id="cite_ref-pmid17477916_40-0"><a href="#cite_note-pmid17477916-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid17098298_41-0"><a href="#cite_note-pmid17098298-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> norepinephrine in the hypothalamus and ventrolateral preoptic nucleus,<span class="mw-ref" id="cite_ref-de_Saint_Hilaire_2001_42-0"><a href="#cite_note-de_Saint_Hilaire_2001-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-pmid14998233_43-0"><a href="#cite_note-pmid14998233-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> and <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a> in the amygdala and frontal cortex.<span class="mw-ref" id="cite_ref-Ferraro_2002_44-0"><a href="#cite_note-Ferraro_2002-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> Modafinil was screened at a large panel of receptors and transporters in an attempt to elucidate its pharmacology.<span class="mw-ref" id="cite_ref-ZolkowskaJain2009_45-0"><a href="#cite_note-ZolkowskaJain2009-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Of the sites tested, it was found to significantly affect only the dopamine transporter (DAT), acting as a dopamine reuptake inhibitor (DRI) with an IC<sub>50</sub> value of 4<span>&nbsp;</span>μM.<span class="mw-ref" id="cite_ref-ZolkowskaJain2009_45-1"><a href="#cite_note-ZolkowskaJain2009-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Subsequently, it was determined that modafinil binds to the same site on the DAT as <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>, but in a different manner.<span class="mw-ref" id="cite_ref-FedericiLatagliata2013_46-0"><a href="#cite_note-FedericiLatagliata2013-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-Okunola-BakareCao2014_47-0"><a href="#cite_note-Okunola-BakareCao2014-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> In accordance, modafinil increases locomotor activity and extracellular dopamine concentrations in animals in a manner similar to the selective DRI <a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">vanoxerine</a> (GBR-12909),<span class="mw-ref" id="cite_ref-Young2009_48-0"><a href="#cite_note-Young2009-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> and also inhibits <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>-induced dopamine release (a common property of DRIs, since DAT transport facilitates methamphetamine's access to its intracellular targets). As such, "modafinil is an exceptionally weak, but apparently very selective, [DAT] inhibitor".<span class="mw-ref" id="cite_ref-Wisor2013_49-0"><a href="#cite_note-Wisor2013-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span>  In addition to animal research, a human positron emission tomography (PET) imaging study found that 200<span>&nbsp;</span>mg and 300<span>&nbsp;</span>mg doses of modafinil resulted in DAT occupancy of 51.4% and 56.9%, respectively, which was described as "close to that of <a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">methylphenidate</a>".<span class="mw-ref" id="cite_ref-KimTateno2014_50-0"><a href="#cite_note-KimTateno2014-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> Another human PET imaging study similarly found that modafinil occupied the DAT and also determined that it significantly elevated extracellular levels of dopamine in the brain, including in the nucleus accumbens.<span class="mw-ref" id="cite_ref-VolkowFowler2009_51-0"><a href="#cite_note-VolkowFowler2009-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>

<p>Modafinil has been described as an "atypical" DAT inhibitor, and shows a profile of effects that is very different from those of other dopaminergic stimulants.<span class="mw-ref" id="cite_ref-ReithBlough2015_52-0"><a href="#cite_note-ReithBlough2015-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-QuisenberryBaker2015_53-0"><a href="#cite_note-QuisenberryBaker2015-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> For instance, modafinil produces wakefulness reportedly without the need for compensatory sleep, and shows a relatively low, if any,<span class="mw-ref" id="cite_ref-MereuBonci2013_54-0"><a href="#cite_note-MereuBonci2013-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> potential for abuse.<span class="mw-ref" id="cite_ref-Wisor2013_49-1"><a href="#cite_note-Wisor2013-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-ReithBlough2015_52-1"><a href="#cite_note-ReithBlough2015-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-QuisenberryBaker2015_53-1"><a href="#cite_note-QuisenberryBaker2015-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Aside from modafinil, examples of other atypical DAT inhibitors include vanoxerine and <a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benztropine" title="Benztropine" class="mw-redirect">benztropine</a>, which have a relatively low abuse potential similarly to modafinil.<span class="mw-ref" id="cite_ref-ReithBlough2015_52-2"><a href="#cite_note-ReithBlough2015-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> These drugs appear to interact molecularly with the DAT in a distinct way relative to "conventional" DAT blockers such as cocaine and methylphenidate.<span class="mw-ref" id="cite_ref-Okunola-BakareCao2014_47-1"><a href="#cite_note-Okunola-BakareCao2014-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-ReithBlough2015_52-3"><a href="#cite_note-ReithBlough2015-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="DAT-independent_actions">DAT-independent actions</h4></summary>
    
<p>Against the hypothesis that modafinil exerts its effects by acting as a DRI, tyrosine hydroxylase inhibitors (which deplete dopamine) fail to block the effects of modafinil in animals.<span class="mw-ref" id="cite_ref-StickgoldWalker2010_55-0"><a href="#cite_note-StickgoldWalker2010-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> In addition, modafinil fails to reverse <a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">reserpine</a>-induced akinesia, whereas <a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">dextroamphetamine</a>, a dopamine releasing agent (DRA), is able to do so.<span class="mw-ref" id="cite_ref-pmid8998404_56-0"><a href="#cite_note-pmid8998404-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Moreover, one of the first published structure-activity relationship studies of modafinil found in 2012 that DAT inhibition did not correlate with wakefulness-promoting effects in animals among modafinil analogues, and a variety of analogues without any significant inhibition of the DAT still produced wakefulness-promoting effects.<span class="mw-ref" id="cite_ref-DunnHostetler2012_57-0"><a href="#cite_note-DunnHostetler2012-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> Furthermore, "[the] neurochemical effects [of modafinil] and anatomical pattern of brain area activation differ from typical psychostimulants and are consistent with its beneficial effects on cognitive performance processes such as attention, learning, and memory",<span class="mw-ref" id="cite_ref-MereuBonci2013_54-1"><a href="#cite_note-MereuBonci2013-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> and a study found that modafinil-induced increased locomotor activity in animals was dependent on histamine release and could be abolished by depletion of neuronal histamine, whereas those of methylphenidate were not and could not be.<span class="mw-ref" id="cite_ref-IshizukaMurakami2008_39-1"><a href="#cite_note-IshizukaMurakami2008-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> As such, although it is established that modafinil is a clinically significant DRI, its full pharmacology remains unclear and may be more complex than this single property (i.e., may also include DAT-independent actions, such as "activation of the orexin system").<span class="mw-ref" id="cite_ref-FedericiLatagliata2013_46-1"><a href="#cite_note-FedericiLatagliata2013-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-MereuBonci2013_54-2"><a href="#cite_note-MereuBonci2013-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>

<p>In any case, there is nonetheless a good deal of evidence to indicate that modafinil is producing at least a portion of its wakefulness-promoting effects by acting as a DRI, or at least via activation of the dopaminergic system. In support of modafinil acting as a dopaminergic agent, its wakefulness-promoting effects are abolished in DAT knockout mice (although it is important to note that DAT knockout mice show D<sub>1</sub> and D<sub>2</sub> receptor and norepinephrine compensatory abnormalities, which might confound this finding), reduced by both D<sub>1</sub> and D<sub>2</sub> receptor antagonists (although conflicting reports exist),<span class="mw-ref" id="cite_ref-pmid8998404_56-1"><a href="#cite_note-pmid8998404-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> and completely blocked by simultaneous inactivation of both D<sub>1</sub> and D<sub>2</sub> receptors.<span class="mw-ref" id="cite_ref-Wisor2013_49-2"><a href="#cite_note-Wisor2013-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> In accordance, modafinil shows full stimulus generalization to other DAT inhibitors including cocaine, methylphenidate, and vanoxerine, and discrimination is blocked by administration of both ecopipam (SCH-39166), a D<sub>1</sub> receptor antagonist, and <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, a D<sub>2</sub> receptor antagonist.<span class="mw-ref" id="cite_ref-QuisenberryBaker2015_53-2"><a href="#cite_note-QuisenberryBaker2015-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> Partial substitution was seen with the DRA dextroamphetamine and the D<sub>2</sub> receptor agonist PNU-91356A, as well as with <a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">nicotine</a> (which indirectly elevates dopamine levels through activation of nicotinic acetylcholine receptors).<span class="mw-ref" id="cite_ref-QuisenberryBaker2015_53-3"><a href="#cite_note-QuisenberryBaker2015-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span></p>

<p>Modafinil may possess yet an additional mechanism of action. Both modafinil and its metabolite, modafinil sulfone, possess anticonvulsant properties in animals, and modafinil sulfone is nearly as potent as modafinil in producing this effect.<span class="mw-ref" id="cite_ref-pmid15260124_58-0"><a href="#cite_note-pmid15260124-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> However, modafinil sulfone lacks any wakefulness-promoting effects in animals, indicating that a distinct mechanism may be at play in the anticonvulsant effects of both compounds.<span class="mw-ref" id="cite_ref-pmid15260124_58-1"><a href="#cite_note-pmid15260124-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="D2_receptor_partial_agonist">D<sub>2</sub> receptor partial agonist</h4></summary>
    
<p>The (<i>R</i>)-enantiomer of modafinil, known as armodafinil, was also subsequently found to act as a D<sub>2</sub><sup>High</sup> receptor partial agonist, with a K<sub>i</sub> of 16<span>&nbsp;</span>nM, an intrinsic activity of 48%, and an EC<sub>50</sub> of 120<span>&nbsp;</span>nM, in rat striatal tissue.<span class="mw-ref" id="cite_ref-pmid19391150_59-0"><a href="#cite_note-pmid19391150-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> The (<i>S</i>)-enantiomer is inactive with respect to the D<sub>2</sub> receptor.<span class="mw-ref" id="cite_ref-pmid19391150_59-1"><a href="#cite_note-pmid19391150-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> Modafinil has been found to directly inhibit the firing of midbrain dopaminergic neurons in the ventral tegmental area and substantia nigra of rats via activation of D<sub>2</sub> receptors.<span class="mw-ref" id="cite_ref-KorotkovaKlyuch2007_60-0"><a href="#cite_note-KorotkovaKlyuch2007-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Research">Research</h3></summary>
    
<p>An <i>in vitro</i> study predicts that modafinil may induce the cytochrome P450 enzymes CYP1A2, CYP3A4, and CYP2B6, as well as may inhibit CYP2C9 and CYP2C19.<span class="mw-ref" id="cite_ref-pmid10820139_5-1"><a href="#cite_note-pmid10820139-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It may also induce P-glycoprotein (Pgp), which may affect drugs transported by Pgp, such as <a href="Digoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digoxin" title="Digoxin">digoxin</a>.<span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span> The bioavailability of modafinil is greater than 80% of the administered dose. <i>In vitro</i> measurements indicate that 60% of modafinil is bound to plasma proteins at clinical concentrations of the drug. This percentage actually changes very little when the concentration is varied.<span class="mw-ref" id="cite_ref-Hardman_62-0"><a href="#cite_note-Hardman-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>

<p>None of these findings have been confirmed in clinical studies yet.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>C<sub>max</sub> (peak levels) occurs approximately 2–3<span>&nbsp;</span>hours after administration. Food slows absorption, but does not affect the total AUC(AUC – area under the curve – meaning, food may slow absorption, but the total amount of the chemical will be absorbed with or without food). Half-life is generally in the 10–12 hour range, subject to differences in CYP genotypes, liver function and renal function. It is metabolized in the liver, and its inactive metabolite is excreted in the urine. Urinary excretion of the unchanged drug ranges from 0% to as high as 18.7%, depending on various factors.<span class="mw-ref" id="cite_ref-Hardman_62-1"><a href="#cite_note-Hardman-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>

<p>The two major circulating metabolites of modafinil are modafinil acid (CRL-40467) and modafinil sulfone (CRL-41056).<span class="mw-ref" id="cite_ref-SchwertnerKong2005_63-0"><a href="#cite_note-SchwertnerKong2005-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-RobertsonHellriegel2003_4-1"><a href="#cite_note-RobertsonHellriegel2003-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Both of these metabolites have been described as inactive,<span class="mw-ref" id="cite_ref-WongWang1998_64-0"><a href="#cite_note-WongWang1998-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> and neither appear to contribute to the wakefulness-promoting effects of modafinil.<span class="mw-ref" id="cite_ref-SchwertnerKong2005_63-1"><a href="#cite_note-SchwertnerKong2005-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-RobertsonHellriegel2003_4-2"><a href="#cite_note-RobertsonHellriegel2003-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Robertson2002_65-0"><a href="#cite_note-Robertson2002-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> However, modafinil sulfone does appear to possess anticonvulsant effects, and this is a property that it shares with modafinil.<span class="mw-ref" id="cite_ref-pmid15260124_58-2"><a href="#cite_note-pmid15260124-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<style data-mw-deduplicate="TemplateStyles:r923042769/mw-parser-output/.tmulti">.mw-parser-output .tmulti .thumbinner{display:flex;flex-direction:column}.mw-parser-output .tmulti .trow{display:flex;flex-direction:row;clear:left;flex-wrap:wrap;width:100%;box-sizing:border-box}.mw-parser-output .tmulti .tsingle{margin:1px;float:left}.mw-parser-output .tmulti .theader{clear:both;font-weight:bold;text-align:center;align-self:center;background-color:transparent;width:100%}.mw-parser-output .tmulti .thumbcaption{text-align:left;background-color:transparent}.mw-parser-output .tmulti .thumbcaption-center{text-align:center;background-color:transparent}.mw-parser-output .tmulti .text-align-left{text-align:left}.mw-parser-output .tmulti .text-align-right{text-align:right}.mw-parser-output .tmulti .text-align-center{text-align:center}@media all and (max-width:720px){.mw-parser-output .tmulti .thumbinner{width:100%!important;box-sizing:border-box;max-width:none!important;align-items:center}.mw-parser-output .tmulti .trow{justify-content:center}.mw-parser-output .tmulti .tsingle{float:none!important;max-width:100%!important;box-sizing:border-box;text-align:center}.mw-parser-output .tmulti .thumbcaption{text-align:center}}</style><div class="thumb tmulti tright"><div class="thumbinner" style="width:448px;max-width:448px"><div class="trow"><div class="tsingle" style="width:222px;max-width:222px"><div class="thumbimage"><figure-inline><img src="../I/m/(R)-(−)-modafinil.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/(R)-(%E2%88%92)-modafinil.svg.png" data-file-width="512" data-file-height="408" data-file-type="drawing" height="175" width="220"></figure-inline></div><div class="thumbcaption">The (<i>R</i>)-(−)-enantiomer of modafinil<span class="mw-ref" id="cite_ref-LolandMereu2012_66-0"><a href="#cite_note-LolandMereu2012-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></div></div><div class="tsingle" style="width:222px;max-width:222px"><div class="thumbimage"><figure-inline><img src="../I/m/(S)-(+)-modafinil.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/(S)-(%2B)-modafinil.svg.png" data-file-width="512" data-file-height="408" data-file-type="drawing" height="175" width="220"></figure-inline></div><div class="thumbcaption">The <i>S</i>-(+)-enantiomer of modafinil<span class="mw-ref" id="cite_ref-LolandMereu2012_66-1"><a href="#cite_note-LolandMereu2012-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></div></div></div></div></div>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Measurement_in_body_fluids">Measurement in body fluids</h3></summary>
    
<p>Modafinil and/or its major metabolite, modafinil acid, may be quantified in plasma, serum or urine to monitor dosage in those receiving the drug therapeutically, to confirm a diagnosis of poisoning in hospitalized patients or to assist in the forensic investigation of a vehicular traffic violation. Instrumental techniques involving gas or liquid chromatography are usually employed for these purposes.<span class="mw-ref" id="cite_ref-pmid9549666_67-0"><a href="#cite_note-pmid9549666-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-isbn0-9626523-7-7_68-0"><a href="#cite_note-isbn0-9626523-7-7-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span> As of 2011, it is not specifically tested for by common drug screens (except for anti-doping screens) and is unlikely to cause false positives for other chemically-unrelated drugs such as substituted amphetamines.</p>

<p>Reagent testing can be used to screen for the presence of modafinil in samples.</p>

<table class="wikitable">
<caption>Colors produced by modafinil with various reagents</caption>
<tbody><tr>
<th>RC</th>
<th>Marquis Reagent</th>
<th>Liebermann</th>
<th>Froehde</th></tr>
<tr>
<td>Modafinil</td><td>Yellow/Orange &gt; Brown<span class="mw-ref" id="cite_ref-DesignerTryp_69-0"><a href="#cite_note-DesignerTryp-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span><span class="mw-ref" id="cite_ref-RTUK_Modafinil_70-0"><a href="#cite_note-RTUK_Modafinil-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></td><td>Darkening Orange<span class="mw-ref" id="cite_ref-DesignerTryp_69-1"><a href="#cite_note-DesignerTryp-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span></td><td>Deep orange/red<span class="mw-ref" id="cite_ref-RTUK_Modafinil_70-1"><a href="#cite_note-RTUK_Modafinil-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span></td></tr>
</tbody></table>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Structural_analogs">Structural analogs</h3></summary>
    

<p>Modafinil is a highly researched compound, with many derivatives created and studied, some examples and their differences between dopamine, serotonin &amp; norepinephrine affect is given in bundled table form below.</p>


<table class="wikitable mw-collapsible mw-collapsed">
<tbody><tr>
<th>Pharmacology of modafinil's structural analogs</th></tr>
<tr style="text-align: left; style=">
<td>
<table class="wikitable sortable">
<caption>Modafinil analogs and their effects on the central nervous system.<span class="mw-ref" id="cite_ref-De_RisiFerraro2008_71-0"><a href="#cite_note-De_RisiFerraro2008-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span></caption>
<tbody><tr><th>Structure</th>
<th>X<sub>1</sub></th>
<th>X<sub>2</sub></th>
<th>NR<sub>1</sub>R<sub>2</sub></th>
<th>Action on CNS</th></tr>
<tr>
<td rowspan="10"><figure-inline><img src="../I/m/Modafinil_analogs_1.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Modafinil_analogs_1.svg.png" data-file-width="512" data-file-height="296" data-file-type="drawing" height="145" width="250"></figure-inline></td></tr>
<tr>
<td>H</td><td>H</td><td>NHCH<sub>3</sub></td><td>Stimulating</td></tr>
<tr>
<td>H</td><td>H</td><td>NHCH(CH<sub>3</sub>)<sub>2</sub></td><td>Stimulating</td></tr>
<tr>
<td>H</td><td>H</td><td>NHC(CH<sub>3</sub>)<sub>3</sub></td><td>Stimulating</td></tr>
<tr>
<td>H</td><td>H</td><td>NHCH<sub>2</sub>CH<sub>3</sub></td><td>Sedative</td></tr>
<tr>
<td>H</td><td>H</td><td>Piperidine</td><td>Sedative</td></tr>
<tr>
<td>H</td><td>H</td><td>Morfoline</td><td>Sedative</td></tr>
<tr>
<td>4-Cl</td><td>H</td><td>NH<sub>2</sub></td><td>Stimulating</td></tr>
<tr>
<td>4-F</td><td>4-F</td><td>NH<sub>2</sub></td><td>Stimulating</td></tr>
<tr>
<td>4-F</td><td>H</td><td>NH<sub>2</sub></td><td>Stimulating</td></tr>
</tbody></table>
<table class="wikitable sortable">
<caption>Thio- &amp; Sulfinylacetamide Modafinil analogs<span class="mw-ref" id="cite_ref-Okunola-BakareCao2014_47-2"><a href="#cite_note-Okunola-BakareCao2014-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></caption>
<tbody><tr><th>Structure</th>
<th><i>X</i><br>(di-benzene substitutions)</th>
<th><i>Y</i><br>(CH<sub>2</sub> substitution)</th>
<th><i>R</i><br>(<i>N</i>-methyl terminating substitution)</th>
<th><i>K</i><sub>i</sub><span> [</span>SE interval<span>]</span> (<i>nM</i>)<br>@ DAT</th>
<th><i>K</i><sub>i</sub><span> [</span>SE interval<span>]</span> (<i>nM</i>)<br>@ SERT</th>
<th><i>K</i><sub>i</sub><span> [</span>SE interval<span>]</span> (<i>nM</i>)<br>@ NET</th></tr>
<tr>
<td>Modafinil</td><td>H</td><td>S=O</td><td>H</td><td>2600 (2430—2780)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td rowspan="31"><figure-inline><img src="../I/m/Modafinil_analogs_2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Modafinil_analogs_2.svg.png" data-file-width="512" data-file-height="317" data-file-type="drawing" height="155" width="250"></figure-inline></td></tr>
<tr>
<td>H</td><td>S</td><td>H</td><td>12400 (10800—14300)</td><td>14500 (11800—17700)</td><td><i>inactive</i><small><br>derived as<br>285000 (117000—690000)</small></td></tr>
<tr>
<td>3,3′-di-Cl</td><td>S</td><td>H</td><td>275 (257—295)</td><td><i>inactive</i><small><br>derived as<br>808000 (706000—924000)</small></td><td>45400 (39600—52000)</td></tr>
<tr>
<td>H</td><td>S</td><td>CH<sub>3</sub></td><td>19300 (17900—20800)</td><td><i>inactive</i><small><br>derived as<br>656000 (302000—1420000)</small></td><td>27200 (25700—28900)</td></tr>
<tr>
<td>4,4′-di-Cl</td><td>S</td><td>CH<sub>3</sub></td><td>4130 (3620—4710)</td><td>10700 (7310—15700)</td><td>9770 (9170—10400)</td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td>CH<sub>3</sub></td><td>3010 (2770—3260)</td><td>5720 (5320—6150)</td><td>11000 (9540—12600)</td></tr>
<tr>
<td>H</td><td>S</td><td>allyl</td><td>8370 (6680—10500)</td><td><i>inactive</i><small><br>derived as<br>303000 (267000—344000)</small></td><td><i>inactive</i><small><br>derived as<br>171000 (88300—332000)</small></td></tr>
<tr>
<td>H</td><td>S</td><td><i>n</i>-propyl</td><td>20700 (20300—21100)</td><td><i>inactive</i><br>derived as<br>419000 (240000—729000)</td><td>68000 (53200—86900)</td></tr>
<tr>
<td>4,4′-di-F</td><td>S</td><td><i>n</i>-propyl</td><td>11700 (10300—13200)</td><td>44200 (38700—50500)</td><td>59700 (51200—69600)</td></tr>
<tr>
<td>4,4′-di-Cl</td><td>S</td><td><i>n</i>-propyl</td><td>1240 (1120—1380)</td><td>10100 (8900—11400)</td><td>7540 (6830—8330)</td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td><i>n</i>-propyl</td><td>590 (550—632)</td><td>8900 (8150—9720)</td><td>10600 (9980—11300)</td></tr>
<tr>
<td>H</td><td>S</td><td>cyclopropylmethyl</td><td>13600 (11900—15600)</td><td>20500 (17500—23900)</td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-F</td><td>S</td><td>cyclopropylmethyl</td><td>6700 (5730—7830)</td><td>34000 (28800—40200)</td><td>57000 (51500—63000)</td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td>cyclopropylmethyl</td><td>975 (852—1110)</td><td>7030 (6040—8180)</td><td><i>inactive</i></td></tr>
<tr>
<td>H</td><td>S</td><td><i>n</i>-butyl</td><td>23600 (20500—27100)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-F</td><td>S</td><td><i>n</i>-butyl</td><td>6400 (5820—7050)</td><td>25500 (23300—28000)</td><td>56100 (53900—58500)</td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td><i>n</i>-butyl</td><td>722 (659—792)</td><td>7090 (6990—8180)</td><td>7580 (7210—7970)</td></tr>
<tr>
<td>H</td><td>S</td><td>3-phenylpropyl</td><td>2020 (1990—2050)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-F</td><td>S</td><td>3-phenylpropyl</td><td>442 (385—509)</td><td>3500 (2950—4160)</td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-Cl</td><td>S</td><td>3-phenylpropyl</td><td>223 (191—260)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td>3-phenylpropyl</td><td>238 (202—280)</td><td>60700 (58400—63200)</td><td>35500 (31700—39800)</td></tr>
<tr>
<td>H</td><td>S</td><td>4-phenylbutyl</td><td>1150 (1020—1290)</td><td><i>inactive</i></td><td>7960 (7590—8350)</td></tr>
<tr>
<td>4,4′-di-Br</td><td>S</td><td>4-phenylbutyl</td><td>405 (348—471)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-CH<sub>3</sub></td><td>S=O</td><td>H</td><td>12700 (12400—13100)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-CF<sub>3</sub></td><td>S=O</td><td>H</td><td>35400 (34100—36700)</td><td>not tested</td><td>not tested</td></tr>
<tr>
<td>3,3′-di-F</td><td>S=O</td><td>H</td><td>5930 (4990—7060)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>3,3′-di-Cl</td><td>S=O</td><td>H</td><td>881 (763—1020)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>H, 3-Br</td><td>S=O</td><td>H</td><td>550 (542—557)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>H</td><td>S=O</td><td>CH<sub>3</sub></td><td>13100 (12600—13700)</td><td><i>inactive</i></td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-Br</td><td>S=O</td><td>3-phenylpropyl</td><td>1280 (1160—1400)</td><td>892 (787—1010)</td><td><i>inactive</i></td></tr>
<tr>
<td>4,4′-di-Cl</td><td>S</td><td>H</td><td>2200 (2060—2390)</td><td>38800 (36400—41300)</td><td>51400 (46000—57500)</td></tr>
</tbody></table></td></tr>
</tbody></table> 


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="History">History</h3></summary>
    
<p>Modafinil was originally developed in France by neurophysiologist professor Michel Jouvet and Lafon Laboratories. Modafinil originated with the late 1970s invention of a series of benzhydryl sulfinyl compounds, including <a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">adrafinil</a>, which was first offered as an experimental treatment for narcolepsy in France in 1986. Modafinil is the primary metabolite of adrafinil, lacking the polar -OH group on its terminal amide,<span class="mw-ref" id="cite_ref-Ballas_72-0"><a href="#cite_note-Ballas-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> and has similar activity to the parent drug but is much more widely used. It has been prescribed in France since 1994 under the name Modiodal, and in the US since 1998 as Provigil.</p>

<p>In 1998, modafinil was approved by the U.S. Food and Drug Administration<span class="mw-ref" id="cite_ref-73"><a href="#cite_note-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> for the treatment of narcolepsy and in 2003 for shift work sleep disorder and obstructive sleep apnea/hypopnea<span class="mw-ref" id="cite_ref-74"><a href="#cite_note-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> even though caffeine and amphetamine were shown to be more wakefulness promoting on the Stanford Sleepiness Test Score than modafinil.<span class="mw-ref" id="cite_ref-pmid19300566_37-2"><a href="#cite_note-pmid19300566-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>

<p>It was approved for use in the UK in December 2002. Modafinil is marketed in the United States by Cephalon, who originally leased the rights from Lafon, but eventually purchased the company in 2001.</p>

<p>Cephalon began to market armodafinil, the (<i>R</i>)-enantiomer of modafinil, in the United States in 2007. After protracted patent litigation and negotiations (see <a href="#Patent_protection_and_antitrust_litigation">below</a>), generic versions of modafinil became available in the US in 2012.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Patent_protection_and_antitrust_litigation">Patent protection and antitrust litigation</h3></summary>
    
<p><span><a href="javascript:if(confirm('https://www.google.com/patents/US4927855  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US4927855'" tppabs="https://www.google.com/patents/US4927855" class="external text external">U.S. Patent 4,927,855</a></span> was issued to <span class="new">Laboratoire L. Lafon</span> on May 22, 1990, covering the chemical compound modafinil. After receiving an interim term extension of 1066<span>&nbsp;</span>days and pediatric exclusivity of six months, it expired on October 22, 2010. On October 6, 1994, Cephalon filed an additional patent, covering modafinil in the form of particles of defined size. That patent, <span><a href="javascript:if(confirm('https://www.google.com/patents/US5618845  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US5618845'" tppabs="https://www.google.com/patents/US5618845" class="external text external">U.S. Patent 5,618,845</a></span> was issued on April 8, 1997. It was reissued in 2002 as RE 37,516, which surrendered the 5618845 patent. With pediatric exclusivity, this patent expired on April 6, 2015.<span class="mw-ref" id="cite_ref-75"><a href="#cite_note-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span><span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span></p>

<p>On December 24, 2002, anticipating the expiration of exclusive marketing rights, generic drug manufacturers Mylan, Teva, Barr, and Ranbaxy applied to the FDA to market a generic form of modafinil.<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> At least one withdrew its application after early opposition by Cephalon based on the RE 37,516 patent. There is some question of whether a particle size patent is sufficient protection against the manufacture of generics. Pertinent questions include whether modafinil may be modified or manufactured to avoid the granularities specified in the new Cephalon patent, and whether patenting particle size is invalid because particles of appropriate sizes are likely to be obvious to practitioners skilled in the art. However, under United States patent law, a patent is entitled to a legal presumption of validity, meaning that in order to invalidate the patent, much more than "pertinent questions" are required.</p>

<p>As of October 31, 2011, U.S. Reissue Patent No. RE 37,516 has been declared invalid and unenforceable.<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> The District Court for the Eastern District of Pennsylvania ruled that RE 37,516 was invalid because it: (1) was on sale more than one year prior to the date of the application in violation of 35 U.S.C. section 102(b); (2) was actually invented by someone else (the French company Laboratoire L. Lafon); (3) was obvious at the time the invention was made to a person having ordinary skill in the art under 35 U.S.C. section 103(a); and (4) failed the written description requirement of 35 U.S.C. section 112.<span class="mw-ref" id="cite_ref-url_Justia_79-0"><a href="#cite_note-url_Justia-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> The patent was also found to be unenforceable due to Cephalon's inequitable conduct during patent prosecution.<span class="mw-ref" id="cite_ref-url_Justia_79-1"><a href="#cite_note-url_Justia-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span></p>

<p>Cephalon made an agreement with four major generics manufacturers Teva, Barr Pharmaceuticals, Ranbaxy Laboratories, and Watson Pharmaceuticals between 2005 and 2006 to delay sales of generic modafinil in the US until April 2012 by these companies in exchange for upfront and royalty payments.<span class="mw-ref" id="cite_ref-80"><a href="#cite_note-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> Litigation arising from these agreements is still pending including an FTC suit filed in April 2008.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> Apotex received regulatory approval in Canada despite a suit from Cephalon's marketing partner in Canada, Shire Pharmaceuticals.<span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> Cephalon has sued Apotex in the US to prevent it from releasing a genericized armodafinil (Nuvigil).<span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> Cephalon's 2011 attempt to merge with Teva was approved by the FTC under a number of conditions, including granting generic US rights to another company;<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> ultimately, Par Pharmaceutical acquired the US modafinil rights as well as some others.<span class="mw-ref" id="cite_ref-url_Par_Pharmaceutical_86-0"><a href="#cite_note-url_Par_Pharmaceutical-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></p>

<p>In the United Kingdom, Mylan Inc. received regulatory approval to sell generic modafinil produced by Orchid in January 2010; Cephalon sued to prevent sale, but lost the patent trial in November.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="United_States">United States</h4></summary>
    
<p>Modafinil is <span>currently</span> classified as a Schedule IV controlled substance under United States federal law; it is illegal to import by anyone other than a <a href="Drug_Enforcement_Administration.htm" tppabs="https://ptable.com/wiki/compounds/A/Drug_Enforcement_Administration" title="Drug Enforcement Administration">DEA</a>-registered importer without a prescription.<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span> However, one may legally bring modafinil into the United States in person from a foreign country, provided that he or she has a prescription for it, and the drug is properly declared at the border crossing. U.S. residents are limited to 50 dosage units (e.g., pills).<span class="mw-ref" id="cite_ref-89"><a href="#cite_note-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> Under the US Pure Food and Drug Act, drug companies are not allowed to market their drugs for off-label uses (conditions other than those officially approved by the FDA);<span class="mw-ref" id="cite_ref-90"><a href="#cite_note-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span> Cephalon was reprimanded in 2002 by the FDA because its promotional materials were found to be "false, lacking in fair balance, or otherwise misleading".<span class="mw-ref" id="cite_ref-91"><a href="#cite_note-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span> Cephalon pleaded guilty to a criminal violation and paid several fines, including <span class="nowrap">$50<span>&nbsp;</span>million</span> and <span class="nowrap">$425<span>&nbsp;</span>million</span> fines to the U.S. government in 2008.<span class="mw-ref" id="cite_ref-92"><a href="#cite_note-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="China">China</h4></summary>
    
<p>In mainland China, modafinil is strictly controlled like other stimulants, such as amphetamines and <a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">methylphenidate</a>. It has been classified as Class I psychotropic drug,<span class="mw-ref" id="cite_ref-94"><a href="#cite_note-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span> meaning that only doctors who have the right to prescribe narcotics and Class I psychotropic drugs (usually through special examination) can prescribe it for no more than three-day use (or seven-day use for control/extend-release products).<span class="mw-ref" id="cite_ref-95"><a href="#cite_note-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span> The first and only modafinil products was approved in November 2017,<span class="mw-ref" id="cite_ref-96"><a href="#cite_note-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> but its marketing status in mainland China is still unknown.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Japan">Japan</h4></summary>
    
<p>In Japan, modafinil is Schedule I psychotropic drug.<span class="mw-ref" id="cite_ref-97"><a href="#cite_note-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span><span class="mw-ref" id="cite_ref-98"><a href="#cite_note-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> Cephalon has licensed Alfresa Corporation to produce, and Mitsubishi Tanabe Pharma to sell modafinil products under the trade name Modiodal in Japan.<span class="mw-ref" id="cite_ref-99"><a href="#cite_note-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span> Also, there have been reported arrests of people who imported modafinil for personal use.<span class="mw-ref" id="cite_ref-100"><a href="#cite_note-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span><span class="mw-ref" id="cite_ref-101"><a href="#cite_note-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Romania">Romania</h4></summary>
    
<p>Modafinil is considered a stimulant doping agent and as such is prohibited in sports competitions, in the same category as steroids.<span class="mw-ref" id="cite_ref-102"><a href="#cite_note-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span> Sanctions range from a simple warning to a 4.000 lei fine, as well as confiscation of the substance.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Russia">Russia</h4></summary>
    
<p>In Russia modafinil is Schedule II controlled substance like <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a> and <a href="Morphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Morphine" title="Morphine">morphine</a>. Possession of few modafinil pills can lead to 3–10 years imprisonment.<span class="mw-ref" id="cite_ref-103"><a href="#cite_note-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Australia">Australia</h4></summary>
    
<p>In Australia, modafinil is considered to be a Schedule 4 prescription-only medicine or prescription animal remedy.<span class="mw-ref" id="cite_ref-104"><a href="#cite_note-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span> Schedule 4 is defined as "Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription."</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Sweden">Sweden</h4></summary>
    
<p>In Sweden, modafinil is classified as a schedule IV substance and possession is therefore illegal without prescription.<span class="mw-ref" id="cite_ref-105"><a href="#cite_note-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_countries">Other countries</h4></summary>
    
<p>The following countries do not classify modafinil as a controlled substance:</p>

<ul><li>Canada (not listed in the Controlled Drugs and Substances Act, but it is a Schedule F prescription drug,<span class="mw-ref" id="cite_ref-106"><a href="#cite_note-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span> so it is subject to seizure by Canada Border Services Agency)</li>
<li>In Finland, modafinil is a prescription drug but not listed as a controlled substance.<span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span></li>
<li>Mexico (Not listed as a controlled substance, in the National Health Law)<span class="mw-ref" id="cite_ref-108"><a href="#cite_note-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span></li>
<li>South Africa Schedule V<span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span></li>
<li>United Kingdom (not listed in Misuse of Drugs Act so possession not illegal, but prescription required) <span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Modafinil is sold under a wide variety of brand names worldwide, including Alertec, Alertex, Altasomil, Aspendos, Forcilin, Intensit, Mentix, Modafinil, Modafinilo, Modalert, Modanil, Modasomil, Modvigil, Modiodal, Modiwake, Movigil, Provigil, Resotyl, Stavigile, Vigia, Vigicer, Vigil, Vigimax, Wakelert and Zalux.<span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Doping_agent">Doping agent</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Sports">Sports</h4></summary>
    
<p>The regulation of modafinil as a doping agent has been controversial in the sporting world, with high-profile cases attracting press coverage since several prominent American athletes have tested positive for the substance. Some athletes who were found to have used modafinil protested that the drug was not on the prohibited list at the time of their offenses.<span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span> However, the World Anti-Doping Agency (WADA) maintains that it was related to already banned substances. The Agency added modafinil to its list of prohibited substances on August 3, 2004, ten days before the start of the 2004 Summer Olympics.</p>

<p>Modafinil has received some publicity in the past when several athletes (such as sprinter Kelli White in 2004, cyclist David Clinger<span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span> and basketball player Diana Taurasi<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span> in 2010, and rower Timothy Grant in 2015<span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span>) were discovered allegedly using it as a performance-enhancing doping agent. (Taurasi and another player, Monique Coker, tested at the same lab, were later cleared.<span class="mw-ref" id="cite_ref-116"><a href="#cite_note-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span>) It is not clear how widespread this practice is. The BALCO scandal brought to light an as-yet unsubstantiated (but widely published) account of Major League Baseball's all-time leading home-run hitter Barry Bonds' supplemental chemical regimen that included modafinil in addition to anabolic steroids and human growth hormone.<span class="mw-ref" id="cite_ref-117"><a href="#cite_note-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span> Modafinil has been shown to prolong exercise time to exhaustion while performing at 85% of VO<sub>2max</sub> and also reduces the perception of effort required to maintain this threshold.<span class="mw-ref" id="cite_ref-118"><a href="#cite_note-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span> Modafinil was added to the World Anti-Doping Agency "Prohibited List" in 2004 as a prohibited stimulant (see <a href="#Legal_status">Modafinil Legal Status</a>).</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Nootropic">Nootropic</h4></summary>
    
<div role="note" class="hatnote navigation-not-searchable">See also: <a href="#Cognitive_enhancement">§<span>&nbsp;</span>Cognitive enhancement</a></div>
<p>Modafinil has been used non-medically as a "smart drug" by students, office workers, <a href="#Military_and_astronauts">soldiers</a> and transhumanists.<span class="mw-ref" id="cite_ref-119"><a href="#cite_note-119" style="counter-reset: mw-Ref 119;"><span class="mw-reflink-text">[119]</span></a></span><span class="mw-ref" id="cite_ref-120"><a href="#cite_note-120" style="counter-reset: mw-Ref 120;"><span class="mw-reflink-text">[120]</span></a></span><span class="mw-ref" id="cite_ref-121"><a href="#cite_note-121" style="counter-reset: mw-Ref 121;"><span class="mw-reflink-text">[121]</span></a></span><span class="mw-ref" id="cite_ref-122"><a href="#cite_note-122" style="counter-reset: mw-Ref 122;"><span class="mw-reflink-text">[122]</span></a></span><span class="mw-ref" id="cite_ref-123"><a href="#cite_note-123" style="counter-reset: mw-Ref 123;"><span class="mw-reflink-text">[123]</span></a></span> As a 'smart drug' it allegedly increases mental focus and helps evade sleep, properties which attract students, professionals in the corporate and tech fields, air-force personnel, surgeons, truck drivers and call-center workers. A survey of 2000 students in the UK in 2014 found that one in five people had used Modafinil to stay awake and study. </p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="ADHD">ADHD</h3></summary>
    
<p>In the United States, an application to market modafinil for pediatric ADHD was submitted to the FDA, but approval was denied due to major concerns over the occurrence of Stevens–Johnson syndrome in clinical trials.<span class="mw-ref" id="cite_ref-124"><a href="#cite_note-124" style="counter-reset: mw-Ref 124;"><span class="mw-reflink-text">[124]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Schizophrenia">Schizophrenia</h3></summary>
    


<p>Modafinil and armodafinil have been studied as a complement to antipsychotic medications in the treatment of schizophrenia. They have been consistently shown to have no effect on positive symptoms or cognitive performance.<span class="mw-ref" id="cite_ref-Kane_D’Souza_Patkar_Youakim_pp._1475–1481_125-0"><a href="#cite_note-Kane_D’Souza_Patkar_Youakim_pp._1475–1481-125" style="counter-reset: mw-Ref 125;"><span class="mw-reflink-text">[125]</span></a></span><span class="mw-ref" id="cite_ref-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21_126-0"><a href="#cite_note-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span> A 2015 meta-analysis found that modafinil and armodafinil may slightly reduce negative symptoms in people with acute schizophrenia, though it does not appear useful for people with the condition who are stable, with high negative symptom scores.<span class="mw-ref" id="cite_ref-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21_126-1"><a href="#cite_note-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21-126" style="counter-reset: mw-Ref 126;"><span class="mw-reflink-text">[126]</span></a></span> Among medications demonstrated to be effective for reducing negative symptoms in combination with anti-psychotics, modafinil and armodafinil are among the smallest effect sizes.<span class="mw-ref" id="cite_ref-Correll_Rubio_Inczedy-Farkas_Birnbaum_127-0"><a href="#cite_note-Correll_Rubio_Inczedy-Farkas_Birnbaum-127" style="counter-reset: mw-Ref 127;"><span class="mw-reflink-text">[127]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Weight_loss">Weight loss</h3></summary>
    
<p>The prescribing information for Provigil notes that "There were no clinically significant differences in body weight change in patients treated with Provigil compared to placebo-treated patients in the placebo-controlled clinical trials."<span class="mw-ref" id="cite_ref-urlprovigil.com_128-0"><a href="#cite_note-urlprovigil.com-128" style="counter-reset: mw-Ref 128;"><span class="mw-reflink-text">[128]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cognitive_enhancement">Cognitive enhancement</h3></summary>
    
<p>A 2015 review of clinical studies of possible nootropic effects in healthy people found: "... whilst most studies employing basic testing paradigms show that modafinil intake enhances executive function, only half show improvements in attention and learning and memory, and a few even report impairments in divergent creative thinking. In contrast, when more complex assessments are used, modafinil appears to consistently engender enhancement of attention, executive functions, and learning. Importantly, we did not observe any preponderances for side effects or mood changes."<span class="mw-ref" id="cite_ref-Battleday2015_8-2"><a href="#cite_note-Battleday2015-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> A 2019 review of a single-dose of modafinil on mental function in healthy, non-sleep deprived people found a small effect and thus limited usefulness as a cognitive enhancer.<span class="mw-ref" id="cite_ref-129"><a href="#cite_note-129" style="counter-reset: mw-Ref 129;"><span class="mw-reflink-text">[129]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Post-chemotherapy_cognitive_impairment">Post-chemotherapy cognitive impairment</h3></summary>
    
<p>Modafinil has been used off-label in trials with people with symptoms of post-chemotherapy cognitive impairment, also known as "chemobrain", but a 2011 review found that it was no better than placebo.<span class="mw-ref" id="cite_ref-130"><a href="#cite_note-130" style="counter-reset: mw-Ref 130;"><span class="mw-reflink-text">[130]</span></a></span> As of 2015 it had been studied for use in multiple sclerosis associated fatigue, but the resulting evidence was weak and inconclusive.<span class="mw-ref" id="cite_ref-Cochrane2015_131-0"><a href="#cite_note-Cochrane2015-131" style="counter-reset: mw-Ref 131;"><span class="mw-reflink-text">[131]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Post-anesthesia_sedation">Post-anesthesia sedation</h3></summary>
    
<p>General anesthesia is required for many surgeries, but there may be lingering fatigue, sedation, and/or drowsiness after surgery has ended that lasts for hours to days. In outpatient settings wherein patients are discharged home after surgery, this sedation, fatigue and occasional dizziness is problematic. As of 2006, modafinil had been tested in one small (N=34) double-blind randomized controlled trial for this use.<span class="mw-ref" id="cite_ref-132"><a href="#cite_note-132" style="counter-reset: mw-Ref 132;"><span class="mw-reflink-text">[132]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<style data-mw-deduplicate="TemplateStyles:r936637989">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style>
<ul><li><a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Armodafinil</li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li>CRL-40,940</li>
<li>CRL-40,941</li>
<li>Fluorenol</li></ul>

<div style="clear:both;"></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHSF2018-1"> <span id="mw-reference-text-cite_note-AHSF2018-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/modafinil.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/modafinil.html'" tppabs="https://www.drugs.com/monograph/modafinil.html" class="external text external">"Modafinil Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">June 24,</span> 2018</span>.</cite></span></li><li id="cite_note-Addiction_liability_review-2"> <span id="mw-reference-text-cite_note-Addiction_liability_review-2" class="mw-reference-text"><cite id="CITEREFMignot2012" class="citation journal cs1">Mignot EJ (October 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574" class="external text external">"A practical guide to the therapy of narcolepsy and hypersomnia syndromes"</a>. <i>Neurotherapeutics</i>. <b>9</b> (4): 739–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs13311-012-0150-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs13311-012-0150-9'" tppabs="https://doi.org/10.1007%2Fs13311-012-0150-9" class="external text external">10.1007/s13311-012-0150-9</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480574" class="external text external">3480574</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23065655  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23065655'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23065655" class="external text external">23065655</a>. <q>Because of the relatively low risk of addiction, modafinil can be more easily prescribed in patients without a clear, biochemically defined central hypersomnia syndrome, and is also easier to stop, if needed. It is also a schedule IV compound.</q></cite></span></li><li id="cite_note-Rare_case_of_modafinil_dependence-3"> <span id="mw-reference-text-cite_note-Rare_case_of_modafinil_dependence-3" class="mw-reference-text"><cite id="CITEREFKrishnanKrishnan2015" class="citation journal cs1">Krishnan, Raman; Krishnan, Chary Vengadaragava (2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252" class="external text external">"A rare case modafinil dependence"</a>. <i>Journal of Pharmacology &amp; Pharmacotherapeutics</i>. J Pharmacol Pharmacotherapy. <b>6</b> (1): 49–50. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2F0976-500X.149149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2F0976-500X.149149'" tppabs="https://doi.org/10.4103%2F0976-500X.149149" class="external text external">10.4103/0976-500X.149149</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319252" class="external text external">4319252</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25709356  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25709356'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25709356" class="external text external">25709356</a>.</cite></span></li><li id="cite_note-RobertsonHellriegel2003-4"> <span id="mw-reference-text-cite_note-RobertsonHellriegel2003-4" class="mw-reference-text"><cite id="CITEREFRobertsonHellriegel2003" class="citation journal cs1">Robertson P, Hellriegel ET (2003). "Clinical pharmacokinetic profile of modafinil". <i>Clinical Pharmacokinetics</i>. <b>42</b> (2): 123–37. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200342020-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200342020-00002'" tppabs="https://doi.org/10.2165%2F00003088-200342020-00002" class="external text external">10.2165/00003088-200342020-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12537513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12537513'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12537513" class="external text external">12537513</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:1266677  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:1266677'" tppabs="https://api.semanticscholar.org/CorpusID:1266677" class="external text external">1266677</a>.</cite></span></li><li id="cite_note-pmid10820139-5"> <span id="mw-reference-text-cite_note-pmid10820139-5" class="mw-reference-text"><cite id="CITEREFRobertsonDeCoryMadanParkinson2000" class="citation journal cs1">Robertson P, DeCory HH, Madan A, Parkinson A (June 2000). "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil". <i>Drug Metabolism and Disposition</i>. <b>28</b> (6): 664–71. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10820139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10820139'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10820139" class="external text external">10820139</a>.</cite></span></li><li id="cite_note-nuvigil.com-6"> <span id="mw-reference-text-cite_note-nuvigil.com-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20180107165205/http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180107165205/http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf'" tppabs="https://web.archive.org/web/20180107165205/http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf" class="external text external">"Nuvigil Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. <i>Nuvigil.com</i>. Archived from <a href="javascript:if(confirm('http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf'" tppabs="http://www.nuvigil.com/PDF/Full_Prescribing_Information.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on January 7, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">January 20,</span> 2019</span>.</cite></span></li><li id="cite_note-FDA2015-7"> <span id="mw-reference-text-cite_note-FDA2015-7" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf" class="external text external">"Provigil Prescribing Information"</a> <span class="cs1-format">(PDF)</span>. <i>United States Food and Drug Administration</i>. Teva Pharmaceuticals USA, Inc. January 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">July 18,</span> 2015</span>.</cite></span></li><li id="cite_note-Battleday2015-8"> <span id="mw-reference-text-cite_note-Battleday2015-8" class="mw-reference-text"><cite id="CITEREFBattledayBrem2015" class="citation journal cs1">Battleday RM, Brem AK (November 2015). <a href="javascript:if(confirm('http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2815%2900249-7/pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2815%2900249-7/pdf'" tppabs="http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2815%2900249-7/pdf" class="external text external">"Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review"</a>. <i>European Neuropsychopharmacology</i>. <b>25</b> (11): 1865–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.euroneuro.2015.07.028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.euroneuro.2015.07.028'" tppabs="https://doi.org/10.1016%2Fj.euroneuro.2015.07.028" class="external text external">10.1016/j.euroneuro.2015.07.028</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26381811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26381811'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26381811" class="external text external">26381811</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:23319688  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:23319688'" tppabs="https://api.semanticscholar.org/CorpusID:23319688" class="external text external">23319688</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFMeulenHallMohammed2017" class="citation book cs1">Meulen, Ruud ter; Hall, Wayne; Mohammed, Ahmed (2017). <a href="javascript:if(confirm('https://books.google.com/books?id=aAIXDgAAQBAJ&pg=PA116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=aAIXDgAAQBAJ&pg=PA116'" tppabs="https://books.google.com/books?id=aAIXDgAAQBAJ&pg=PA116" class="external text external"><i>Rethinking Cognitive Enhancement</i></a>. Oxford University Press. p.<span>&nbsp;</span>116. ISBN<span>&nbsp;</span><bdi>9780198727392</bdi>.</cite></span></li><li id="cite_note-BNF74-10"> <span id="mw-reference-text-cite_note-BNF74-10" class="mw-reference-text"><cite class="citation book cs1"><i>BNF 74</i> (74 ed.). Pharmaceutical Press. September 2017. p.<span>&nbsp;</span>468. ISBN<span>&nbsp;</span><bdi>978-0857112989</bdi>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Modafinil  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Modafinil'" tppabs="https://clincalc.com/DrugStats/Drugs/Modafinil" class="external text external">"Modafinil - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 11,</span> 2020</span>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-06-13/kywb-5uhe  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-06-13/kywb-5uhe'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-06-13/kywb-5uhe" class="external text external">"NADAC as of 2018-06-13"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">June 24,</span> 2018</span>.</cite></span></li><li id="cite_note-SleepAcademy2007-13"> <span id="mw-reference-text-cite_note-SleepAcademy2007-13" class="mw-reference-text"><cite id="CITEREFMorgenthalerLee-ChiongAlessiFriedman2007" class="citation journal cs1">Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Zak R (November 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098" class="external text external">"Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report"</a>. <i>Sleep</i>. <b>30</b> (11): 1445–59. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fsleep%2F30.11.1445  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fsleep%2F30.11.1445'" tppabs="https://doi.org/10.1093%2Fsleep%2F30.11.1445" class="external text external">10.1093/sleep/30.11.1445</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082098" class="external text external">2082098</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18041479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18041479'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18041479" class="external text external">18041479</a>.</cite></span></li><li id="cite_note-pmid23385698-14"> <span id="mw-reference-text-cite_note-pmid23385698-14" class="mw-reference-text"><cite id="CITEREFZeeAttarianVidenovic2013" class="citation journal cs1">Zee PC, Attarian H, Videnovic A (February 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533" class="external text external">"Circadian rhythm abnormalities"</a>. <i>Continuum</i>. <b>19</b> (1 Sleep Disorders): 132–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1212%2F01.CON.0000427209.21177.aa  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2F01.CON.0000427209.21177.aa'" tppabs="https://doi.org/10.1212%2F01.CON.0000427209.21177.aa" class="external text external">10.1212/01.CON.0000427209.21177.aa</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654533" class="external text external">3654533</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23385698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23385698'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23385698" class="external text external">23385698</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text">European Medicines Agency January 27, 2011 <a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Modafinil_31/WC500099177.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Modafinil_31/WC500099177.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Modafinil_31/WC500099177.pdf" class="external text external">Questions and answers on the review of medicines containing Modafinil</a></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFMartin2003" class="citation news cs1">Martin, Richard (November 1, 2003). <a href="javascript:if(confirm('https://www.wired.com/2003/11/sleep/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wired.com/2003/11/sleep/'" tppabs="https://www.wired.com/2003/11/sleep/" class="external text external">"It's Wake-Up Time"</a>. <i>Wired</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1059-1028  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1059-1028'" tppabs="https://www.worldcat.org/issn/1059-1028" class="external text external">1059-1028</a><span class="reference-accessdate">. Retrieved <span class="nowrap">May 23,</span> 2019</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFWheeler_B2006" class="citation news cs1">Wheeler B (October 26, 2006). <a href="javascript:if(confirm('http://news.bbc.co.uk/1/hi/uk_politics/6083840.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/1/hi/uk_politics/6083840.stm'" tppabs="http://news.bbc.co.uk/1/hi/uk_politics/6083840.stm" class="external text external">"BBC report on MoD research into modafinil"</a>. <i>BBC News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.scotsman.com/news/health/mod-s-secret-pep-pill-to-keep-forces-awake-1-1387967  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.scotsman.com/news/health/mod-s-secret-pep-pill-to-keep-forces-awake-1-1387967'" tppabs="http://www.scotsman.com/news/health/mod-s-secret-pep-pill-to-keep-forces-awake-1-1387967" class="external text external">"MoD's secret pep pill to keep forces awake"</a>. <i>The Scotsman</i>. February 27, 2005<span class="reference-accessdate">. Retrieved <span class="nowrap">December 31,</span> 2013</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120319022600/http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120319022600/http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html'" tppabs="https://web.archive.org/web/20120319022600/http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html" class="external text external">"Pilot pill project"</a>. <i>News – City</i>. PuneMirror. February 16, 2011. Archived from <a href="javascript:if(confirm('http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html'" tppabs="http://www.punemirror.in/article/2/201102162011021606331644587714a65/Pilot-pill-project.html" class="external text external">the original</a> on March 19, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-urlwww.dtic.mil-20"> <span id="mw-reference-text-cite_note-urlwww.dtic.mil-20" class="mw-reference-text"><cite id="CITEREFTaylor_GP_JrKeys_RE2003" class="citation web cs1">Taylor GP Jr; Keys RE (December 1, 2003). <a href="javascript:if(confirm('https://web.archive.org/web/20090612082936/http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090612082936/http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf'" tppabs="https://web.archive.org/web/20090612082936/http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf" class="external text external">"Modafinil and management of aircrew fatigue"</a> <span class="cs1-format">(PDF)</span>. United States Department of the Air Force. Archived from <a href="javascript:if(confirm('http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf'" tppabs="http://www.hep.afrl.af.mil/HEPF/Policy/modafinil.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on June 12, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">September 18,</span> 2009</span>.</cite></span></li><li id="cite_note-AF48-21"> <span id="mw-reference-text-cite_note-AF48-21" class="mw-reference-text"><a href="javascript:if(confirm('http://static.e-publishing.af.mil/production/1/afsoc/publication/afi11-202v3_afsocsup/afi11-202v3_afsocsup.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://static.e-publishing.af.mil/production/1/afsoc/publication/afi11-202v3_afsocsup/afi11-202v3_afsocsup.pdf'" tppabs="http://static.e-publishing.af.mil/production/1/afsoc/publication/afi11-202v3_afsocsup/afi11-202v3_afsocsup.pdf" class="external text external">Air Force Special Operations Command Instruction 48–101</a> (sects. 1.7.4), U.S. Air Force Special Operations Command, November 30, 2012.</span></li><li id="cite_note-pmid19487390-22"> <span id="mw-reference-text-cite_note-pmid19487390-22" class="mw-reference-text"><cite id="CITEREFThirskKuipersMukaiWilliams2009" class="citation journal cs1">Thirsk R, Kuipers A, Mukai C, Williams D (June 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437" class="external text external">"The space-flight environment: the International Space Station and beyond"</a>. <i>CMAJ</i>. <b>180</b> (12): 1216–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1503%2Fcmaj.081125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1503%2Fcmaj.081125'" tppabs="https://doi.org/10.1503%2Fcmaj.081125" class="external text external">10.1503/cmaj.081125</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691437" class="external text external">2691437</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19487390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19487390'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19487390" class="external text external">19487390</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036lbl.pdf" class="external text external">"FDA data on Modafinil"</a> <span class="cs1-format">(PDF)</span>. <i>Accessdata.fda.gov</i>. 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">September 9,</span> 2018</span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/downloads/Drugs/DrugSafety/UCM231722.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/Drugs/DrugSafety/UCM231722.pdf'" tppabs="https://www.fda.gov/downloads/Drugs/DrugSafety/UCM231722.pdf" class="external text external">"FDA Provigil Drug Safety Data"</a> <span class="cs1-format">(PDF)</span>. <i>Fda.gov</i>. January 2015.</cite></span></li><li id="cite_note-Modafinilstatpearls-25"> <span id="mw-reference-text-cite_note-Modafinilstatpearls-25" class="mw-reference-text"><cite id="CITEREFGreenblattAdams2019" class="citation journal cs1">Greenblatt, Karl; Adams, Ninos (2019). "Modafinil". <i>StatPearls</i>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30285371  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30285371'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30285371" class="external text external">30285371</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil'" tppabs="https://www.fda.gov/cder/dsn/2007_fall/postmarketing.htm#modafinil" class="external text external">"Modafinil (marketed as Provigil): Serious Skin Reactions"</a>. Food and Drug Administration. 2007.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFBanerjeeVitielloGrunstein2004" class="citation journal cs1">Banerjee D, Vitiello MV, Grunstein RR (October 2004). "Pharmacotherapy for excessive daytime sleepiness". <i>Sleep Medicine Reviews</i>. <b>8</b> (5): 339–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.smrv.2004.03.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.smrv.2004.03.002'" tppabs="https://doi.org/10.1016%2Fj.smrv.2004.03.002" class="external text external">10.1016/j.smrv.2004.03.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15336235  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15336235'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15336235" class="external text external">15336235</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20070610045952/http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070610045952/http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html'" tppabs="https://web.archive.org/web/20070610045952/http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" class="external text external">"MedlinePlus Drug Information: Modafinil"</a>. NIH. July 1, 2005. Archived from <a href="javascript:if(confirm('https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html'" tppabs="https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a602016.html" class="external text external">the original</a> on June 10, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">July 21,</span> 2007</span>.</cite></span></li><li id="cite_note-Modafinil-29"> <span id="mw-reference-text-cite_note-Modafinil-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf" class="external text external">"Provigil: Prescribing information"</a> <span class="cs1-format">(PDF)</span>. <i>United States Food and Drug Administration</i>. Cephalon, Inc. January 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">August 16,</span> 2015</span>.</cite></span></li><li id="cite_note-Ballon-30"> <span id="mw-reference-text-cite_note-Ballon-30" class="mw-reference-text"><cite id="CITEREFBallonFeifel2006" class="citation journal cs1">Ballon JS, Feifel D (April 2006). "A systematic review of modafinil: Potential clinical uses and mechanisms of action". <i>The Journal of Clinical Psychiatry</i>. <b>67</b> (4): 554–66. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2Fjcp.v67n0406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2Fjcp.v67n0406'" tppabs="https://doi.org/10.4088%2Fjcp.v67n0406" class="external text external">10.4088/jcp.v67n0406</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16669720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16669720'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16669720" class="external text external">16669720</a>.</cite></span></li><li id="cite_note-pmid16737742-31"> <span id="mw-reference-text-cite_note-pmid16737742-31" class="mw-reference-text"><cite id="CITEREFNasrWendtSteiner2006" class="citation journal cs1">Nasr S, Wendt B, Steiner K (October 2006). "Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice". <i>Journal of Affective Disorders</i>. <b>95</b> (1–3): 111–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jad.2006.01.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jad.2006.01.010'" tppabs="https://doi.org/10.1016%2Fj.jad.2006.01.010" class="external text external">10.1016/j.jad.2006.01.010</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16737742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16737742'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16737742" class="external text external">16737742</a>.</cite></span></li><li id="cite_note-pmid10828434-32"> <span id="mw-reference-text-cite_note-pmid10828434-32" class="mw-reference-text"><cite id="CITEREFMitlerHarshHirshkowitzGuilleminault2000" class="citation journal cs1">Mitler MM, Harsh J, Hirshkowitz M, Guilleminault C (July 2000). "Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy". <i>Sleep Medicine</i>. <b>1</b> (3): 231–243. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs1389-9457%2800%2900031-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs1389-9457%2800%2900031-9'" tppabs="https://doi.org/10.1016%2Fs1389-9457%2800%2900031-9" class="external text external">10.1016/s1389-9457(00)00031-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10828434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10828434'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10828434" class="external text external">10828434</a>.</cite></span></li><li id="cite_note-pmid9450772-33"> <span id="mw-reference-text-cite_note-pmid9450772-33" class="mw-reference-text"><cite id="CITEREFFry1998" class="citation journal cs1">Fry (January 1998). "Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group". <i>Annals of Neurology</i>. <b>43</b> (1): 88–97. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fana.410430115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fana.410430115'" tppabs="https://doi.org/10.1002%2Fana.410430115" class="external text external">10.1002/ana.410430115</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9450772  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9450772'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9450772" class="external text external">9450772</a>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.tga.gov.au/publication-issue/australian-adverse-drug-reactions-bulletin-vol-27-no-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.tga.gov.au/publication-issue/australian-adverse-drug-reactions-bulletin-vol-27-no-6#a2'" tppabs="https://www.tga.gov.au/publication-issue/australian-adverse-drug-reactions-bulletin-vol-27-no-6#a2" class="external text external">"Australian Adverse Drug Reactions Bulletin 2008"</a> <span class="cs1-format">(etext)</span>. Australian Adverse Drug Reactions Bulletin. December 1, 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">November 29,</span> 2017</span>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFZolkowskaJainRothmanPartilla2009" class="citation journal cs1">Zolkowska, Dorota; Jain, Raka; Rothman, Richard B.; Partilla, John S.; Roth, Bryan L.; Setola, Vincent; Prisinzano, Thomas E.; Baumann, Michael H. (May 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878" class="external text external">"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>329</b> (2): 738–746. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.108.146142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.108.146142'" tppabs="https://doi.org/10.1124%2Fjpet.108.146142" class="external text external">10.1124/jpet.108.146142</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1521-0103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1521-0103'" tppabs="https://www.worldcat.org/issn/1521-0103" class="external text external">1521-0103</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878" class="external text external">2672878</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19197004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19197004'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19197004" class="external text external">19197004</a>.</cite></span></li><li id="cite_note-Stahl's_Essential_Psychopharmacology_-_Modafinil-36"> <span id="mw-reference-text-cite_note-Stahl's_Essential_Psychopharmacology_-_Modafinil-36" class="mw-reference-text"><cite id="CITEREFStahl2017" class="citation book cs1">Stahl SM (March 2017). "Modafinil". <i>Prescriber's Guide: Stahl's Essential Psychopharmacology</i> (6th ed.). Cambridge, United Kingdom: Cambridge University Press. pp.<span>&nbsp;</span>491–495. ISBN<span>&nbsp;</span><bdi>9781108228749</bdi>.</cite></span></li><li id="cite_note-pmid19300566-37"> <span id="mw-reference-text-cite_note-pmid19300566-37" class="mw-reference-text"><cite id="CITEREFGerrardMalcolm2007" class="citation journal cs1">Gerrard P, Malcolm R (June 2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794" class="external text external">"Mechanisms of modafinil: A review of current research"</a>. <i>Neuropsychiatric Disease and Treatment</i>. <b>3</b> (3): 349–64. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794" class="external text external">2654794</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19300566  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19300566'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19300566" class="external text external">19300566</a>.</cite></span></li><li id="cite_note-pmid22640618-38"> <span id="mw-reference-text-cite_note-pmid22640618-38" class="mw-reference-text"><cite id="CITEREFIshizukaMurotaniYamatodani2012" class="citation book cs1">Ishizuka T, Murotani T, Yamatodani A (2012). "Action of modafinil through histaminergic and orexinergic neurons". <i>Sleep Hormones</i>. Vitamins &amp; Hormones. <b>89</b>. pp.<span>&nbsp;</span>259–78. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FB978-0-12-394623-2.00014-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FB978-0-12-394623-2.00014-7'" tppabs="https://doi.org/10.1016%2FB978-0-12-394623-2.00014-7" class="external text external">10.1016/B978-0-12-394623-2.00014-7</a>. ISBN<span>&nbsp;</span><bdi>9780123946232</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22640618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22640618'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22640618" class="external text external">22640618</a>.</cite></span></li><li id="cite_note-IshizukaMurakami2008-39"> <span id="mw-reference-text-cite_note-IshizukaMurakami2008-39" class="mw-reference-text"><cite id="CITEREFIshizukaMurakamiYamatodani2008" class="citation journal cs1">Ishizuka T, Murakami M, Yamatodani A (January 2008). "Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats". <i>European Journal of Pharmacology</i>. <b>578</b> (2–3): 209–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2007.09.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2007.09.009'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2007.09.009" class="external text external">10.1016/j.ejphar.2007.09.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17920581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17920581'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17920581" class="external text external">17920581</a>.</cite></span></li><li id="cite_note-pmid17477916-40"> <span id="mw-reference-text-cite_note-pmid17477916-40" class="mw-reference-text"><cite id="CITEREFDopheideMorganRodveltSchachtman2007" class="citation journal cs1">Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, Miller DK (July 2007). "Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants". <i>European Journal of Pharmacology</i>. <b>568</b> (1–3): 112–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2007.03.044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2007.03.044'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2007.03.044" class="external text external">10.1016/j.ejphar.2007.03.044</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17477916  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17477916'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17477916" class="external text external">17477916</a>.</cite></span></li><li id="cite_note-pmid17098298-41"> <span id="mw-reference-text-cite_note-pmid17098298-41" class="mw-reference-text"><cite id="CITEREFMurillo-RodríguezHaroPalomero-RiveroMillán-Aldaco2007" class="citation journal cs1">Murillo-Rodríguez E, Haro R, Palomero-Rivero M, Millán-Aldaco D, Drucker-Colín R (January 2007). "Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats". <i>Behavioural Brain Research</i>. <b>176</b> (2): 353–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bbr.2006.10.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bbr.2006.10.016'" tppabs="https://doi.org/10.1016%2Fj.bbr.2006.10.016" class="external text external">10.1016/j.bbr.2006.10.016</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17098298  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17098298'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17098298" class="external text external">17098298</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:30192761  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:30192761'" tppabs="https://api.semanticscholar.org/CorpusID:30192761" class="external text external">30192761</a>.</cite></span></li><li id="cite_note-de_Saint_Hilaire_2001-42"> <span id="mw-reference-text-cite_note-de_Saint_Hilaire_2001-42" class="mw-reference-text"><cite id="CITEREFde_Saint_HilaireOroscoRouchBlanc2001" class="citation journal cs1">de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S (November 2001). "Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats". <i>NeuroReport</i>. <b>12</b> (16): 3533–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00001756-200111160-00032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00001756-200111160-00032'" tppabs="https://doi.org/10.1097%2F00001756-200111160-00032" class="external text external">10.1097/00001756-200111160-00032</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11733706  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11733706'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11733706" class="external text external">11733706</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:31726815  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:31726815'" tppabs="https://api.semanticscholar.org/CorpusID:31726815" class="external text external">31726815</a>.</cite></span></li><li id="cite_note-pmid14998233-43"> <span id="mw-reference-text-cite_note-pmid14998233-43" class="mw-reference-text"><cite id="CITEREFGallopinLuppiRambertFrydman2004" class="citation journal cs1">Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P (February 2004). "Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study". <i>Sleep</i>. <b>27</b> (1): 19–25. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14998233  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14998233'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14998233" class="external text external">14998233</a>.</cite></span></li><li id="cite_note-Ferraro_2002-44"> <span id="mw-reference-text-cite_note-Ferraro_2002-44" class="mw-reference-text"><cite id="CITEREFFerraroFuxeTanganelliTomasini2002" class="citation journal cs1">Ferraro L, Fuxe K, Tanganelli S, Tomasini MC, Rambert FA, Antonelli T (April 2002). "Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression". <i>Journal of Neuroscience Research</i>. <b>68</b> (1): 107–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjnr.10196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjnr.10196'" tppabs="https://doi.org/10.1002%2Fjnr.10196" class="external text external">10.1002/jnr.10196</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11933055  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11933055'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11933055" class="external text external">11933055</a>.</cite></span></li><li id="cite_note-ZolkowskaJain2009-45"> <span id="mw-reference-text-cite_note-ZolkowskaJain2009-45" class="mw-reference-text"><cite class="citation journal cs1">Zolkowska D, Jain R, Rothman RB, Partilla JS, Roth BL, Setola V, Prisinzano TE, Baumann MH (May 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878" class="external text external">"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil"</a>. <i>The Journal of Pharmacology and Experimental Therapeutics</i>. <b>329</b> (2): 738–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fjpet.108.146142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fjpet.108.146142'" tppabs="https://doi.org/10.1124%2Fjpet.108.146142" class="external text external">10.1124/jpet.108.146142</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672878" class="external text external">2672878</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19197004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19197004'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19197004" class="external text external">19197004</a>.</cite></span></li><li id="cite_note-FedericiLatagliata2013-46"> <span id="mw-reference-text-cite_note-FedericiLatagliata2013-46" class="mw-reference-text"><cite id="CITEREFFedericiLatagliataRizzoLedonne2013" class="citation journal cs1">Federici M, Latagliata EC, Rizzo FR, Ledonne A, Gu HH, Romigi A, Nisticò R, Puglisi-Allegra S, Mercuri NB (November 2013). "Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation". <i>Neuroscience</i>. <b>252</b>: 118–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neuroscience.2013.07.071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neuroscience.2013.07.071'" tppabs="https://doi.org/10.1016%2Fj.neuroscience.2013.07.071" class="external text external">10.1016/j.neuroscience.2013.07.071</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23933217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23933217'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23933217" class="external text external">23933217</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:7588529  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:7588529'" tppabs="https://api.semanticscholar.org/CorpusID:7588529" class="external text external">7588529</a>.</cite></span></li><li id="cite_note-Okunola-BakareCao2014-47"> <span id="mw-reference-text-cite_note-Okunola-BakareCao2014-47" class="mw-reference-text"><cite id="CITEREFOkunola-BakareCaoKopajticKatz2014" class="citation journal cs1">Okunola-Bakare OM, Cao J, Kopajtic T, Katz JL, Loland CJ, Shi L, Newman AH (February 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497" class="external text external">"Elucidation of structural elements for selectivity across monoamine transporters: novel 2-<span>[</span>(diphenylmethyl)sulfinyl<span>]</span>acetamide (modafinil) analogues"</a>. <i>Journal of Medicinal Chemistry</i>. <b>57</b> (3): 1000–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm401754x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm401754x'" tppabs="https://doi.org/10.1021%2Fjm401754x" class="external text external">10.1021/jm401754x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954497" class="external text external">3954497</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24494745  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24494745'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24494745" class="external text external">24494745</a>.</cite></span></li><li id="cite_note-Young2009-48"> <span id="mw-reference-text-cite_note-Young2009-48" class="mw-reference-text"><cite id="CITEREFYoung2009" class="citation journal cs1">Young JW (March 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968" class="external text external">"Dopamine D1 and D2 receptor family contributions to modafinil-induced wakefulness"</a>. <i>The Journal of Neuroscience</i>. <b>29</b> (9): 2663–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1523%2FJNEUROSCI.5843-08.2009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1523%2FJNEUROSCI.5843-08.2009'" tppabs="https://doi.org/10.1523%2FJNEUROSCI.5843-08.2009" class="external text external">10.1523/JNEUROSCI.5843-08.2009</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697968" class="external text external">2697968</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19261860  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19261860'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19261860" class="external text external">19261860</a>.</cite></span></li><li id="cite_note-Wisor2013-49"> <span id="mw-reference-text-cite_note-Wisor2013-49" class="mw-reference-text"><cite id="CITEREFWisor2013" class="citation journal cs1">Wisor J (October 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559" class="external text external">"Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions"</a>. <i>Frontiers in Neurology</i>. <b>4</b>: 139. doi:<a href="javascript:if(confirm('https://doi.org/10.3389%2Ffneur.2013.00139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3389%2Ffneur.2013.00139'" tppabs="https://doi.org/10.3389%2Ffneur.2013.00139" class="external text external">10.3389/fneur.2013.00139</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791559" class="external text external">3791559</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24109471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24109471'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24109471" class="external text external">24109471</a>.</cite></span></li><li id="cite_note-KimTateno2014-50"> <span id="mw-reference-text-cite_note-KimTateno2014-50" class="mw-reference-text"><cite id="CITEREFKimTatenoArakawaSakayori2014" class="citation journal cs1">Kim W, Tateno A, Arakawa R, Sakayori T, Ikeda Y, Suzuki H, Okubo Y (May 2014). <a href="javascript:if(confirm('https://doi.org/10.1017/S1461145713001612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017/S1461145713001612'" tppabs="https://doi.org/10.1017/S1461145713001612" class="external text external">"In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and <span>[</span>¹⁸F<span>]</span>FE-PE2I"</a>. <i>The International Journal of Neuropsychopharmacology</i>. <b>17</b> (5): 697–703. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1017%2FS1461145713001612  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2FS1461145713001612'" tppabs="https://doi.org/10.1017%2FS1461145713001612" class="external text external">10.1017/S1461145713001612</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24451483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24451483'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24451483" class="external text external">24451483</a>.</cite></span></li><li id="cite_note-VolkowFowler2009-51"> <span id="mw-reference-text-cite_note-VolkowFowler2009-51" class="mw-reference-text"><cite id="CITEREFVolkowFowlerLoganAlexoff2009" class="citation journal cs1">Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K (March 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807" class="external text external">"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications"</a>. <i>JAMA</i>. <b>301</b> (11): 1148–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2009.351  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2009.351'" tppabs="https://doi.org/10.1001%2Fjama.2009.351" class="external text external">10.1001/jama.2009.351</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696807" class="external text external">2696807</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19293415  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19293415'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19293415" class="external text external">19293415</a>.</cite></span></li><li id="cite_note-ReithBlough2015-52"> <span id="mw-reference-text-cite_note-ReithBlough2015-52" class="mw-reference-text"><cite id="CITEREFReithBloughHongJones2015" class="citation journal cs1">Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL (February 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708" class="external text external">"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter"</a>. <i>Drug and Alcohol Dependence</i>. <b>147</b>: 1–19. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.drugalcdep.2014.12.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.drugalcdep.2014.12.005'" tppabs="https://doi.org/10.1016%2Fj.drugalcdep.2014.12.005" class="external text external">10.1016/j.drugalcdep.2014.12.005</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297708" class="external text external">4297708</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25548026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25548026'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25548026" class="external text external">25548026</a>.</cite></span></li><li id="cite_note-QuisenberryBaker2015-53"> <span id="mw-reference-text-cite_note-QuisenberryBaker2015-53" class="mw-reference-text"><cite id="CITEREFQuisenberryBaker2015" class="citation journal cs1">Quisenberry AJ, Baker LE (December 2015). "Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats". <i>Psychopharmacology</i>. <b>232</b> (24): 4411–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-015-4065-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-015-4065-0'" tppabs="https://doi.org/10.1007%2Fs00213-015-4065-0" class="external text external">10.1007/s00213-015-4065-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26374456  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26374456'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26374456" class="external text external">26374456</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:15519396  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:15519396'" tppabs="https://api.semanticscholar.org/CorpusID:15519396" class="external text external">15519396</a>.</cite></span></li><li id="cite_note-MereuBonci2013-54"> <span id="mw-reference-text-cite_note-MereuBonci2013-54" class="mw-reference-text"><cite id="CITEREFMereuBonciNewmanTanda2013" class="citation journal cs1">Mereu M, Bonci A, Newman AH, Tanda G (October 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148" class="external text external">"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders"</a>. <i>Psychopharmacology</i>. <b>229</b> (3): 415–34. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00213-013-3232-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00213-013-3232-4'" tppabs="https://doi.org/10.1007%2Fs00213-013-3232-4" class="external text external">10.1007/s00213-013-3232-4</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800148" class="external text external">3800148</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23934211  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23934211'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23934211" class="external text external">23934211</a>.</cite></span></li><li id="cite_note-StickgoldWalker2010-55"> <span id="mw-reference-text-cite_note-StickgoldWalker2010-55" class="mw-reference-text"><cite id="CITEREFRobert_StickgoldMatthew_P._Walker2010" class="citation book cs1">Robert Stickgold; Matthew P. Walker (May 22, 2010). <a href="javascript:if(confirm('https://books.google.com/books?id=E15ToNvBLcQC&pg=PA191  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=E15ToNvBLcQC&pg=PA191'" tppabs="https://books.google.com/books?id=E15ToNvBLcQC&pg=PA191" class="external text external"><i>The Neuroscience of Sleep</i></a>. Academic Press. pp.<span>&nbsp;</span>191–. ISBN<span>&nbsp;</span><bdi>978-0-12-375722-7</bdi>.</cite></span></li><li id="cite_note-pmid8998404-56"> <span id="mw-reference-text-cite_note-pmid8998404-56" class="mw-reference-text"><cite id="CITEREFSimonHémetRamassamyCostentin1995" class="citation journal cs1">Simon P, Hémet C, Ramassamy C, Costentin J (December 1995). "Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice". <i>European Neuropsychopharmacology</i>. <b>5</b> (4): 509–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0924-977x%2895%2900041-m  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0924-977x%2895%2900041-m'" tppabs="https://doi.org/10.1016%2F0924-977x%2895%2900041-m" class="external text external">10.1016/0924-977x(95)00041-m</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8998404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8998404'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8998404" class="external text external">8998404</a>.</cite></span></li><li id="cite_note-DunnHostetler2012-57"> <span id="mw-reference-text-cite_note-DunnHostetler2012-57" class="mw-reference-text"><cite id="CITEREFDunnHostetlerIqbalMarcy2012" class="citation journal cs1">Dunn D, Hostetler G, Iqbal M, Marcy VR, Lin YG, Jones B, Aimone LD, Gruner J, Ator MA, Bacon ER, Chatterjee S (June 2012). "Wake promoting agents: search for next generation modafinil, lessons learned: part III". <i>Bioorganic &amp; Medicinal Chemistry Letters</i>. <b>22</b> (11): 3751–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bmcl.2012.04.031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bmcl.2012.04.031'" tppabs="https://doi.org/10.1016%2Fj.bmcl.2012.04.031" class="external text external">10.1016/j.bmcl.2012.04.031</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22546675  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22546675'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22546675" class="external text external">22546675</a>.</cite></span></li><li id="cite_note-pmid15260124-58"> <span id="mw-reference-text-cite_note-pmid15260124-58" class="mw-reference-text"><cite id="CITEREFChatterjieStablesWangAlexander2004" class="citation journal cs1">Chatterjie N, Stables JP, Wang H, Alexander GJ (August 2004). "Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity". <i>Neurochemical Research</i>. <b>29</b> (8): 1481–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1023%2Fb%3Anere.0000029559.20581.1a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1023%2Fb%3Anere.0000029559.20581.1a'" tppabs="https://doi.org/10.1023%2Fb%3Anere.0000029559.20581.1a" class="external text external">10.1023/b:nere.0000029559.20581.1a</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15260124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15260124'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15260124" class="external text external">15260124</a>.</cite></span></li><li id="cite_note-pmid19391150-59"> <span id="mw-reference-text-cite_note-pmid19391150-59" class="mw-reference-text"><cite id="CITEREFSeemanGuanHirbec2009" class="citation journal cs1">Seeman P, Guan HC, Hirbec H (August 2009). "Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil". <i>Synapse</i>. <b>63</b> (8): 698–704. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fsyn.20647  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fsyn.20647'" tppabs="https://doi.org/10.1002%2Fsyn.20647" class="external text external">10.1002/syn.20647</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19391150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19391150'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19391150" class="external text external">19391150</a>.</cite></span></li><li id="cite_note-KorotkovaKlyuch2007-60"> <span id="mw-reference-text-cite_note-KorotkovaKlyuch2007-60" class="mw-reference-text"><cite id="CITEREFKorotkovaKlyuchPonomarenkoLin2007" class="citation journal cs1">Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA (February 2007). <a href="javascript:if(confirm('http://www.hal.inserm.fr/inserm-00408025  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.hal.inserm.fr/inserm-00408025'" tppabs="http://www.hal.inserm.fr/inserm-00408025" class="external text external">"Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors"</a>. <i>Neuropharmacology</i>. <b>52</b> (2): 626–33. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.neuropharm.2006.09.005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.neuropharm.2006.09.005'" tppabs="https://doi.org/10.1016%2Fj.neuropharm.2006.09.005" class="external text external">10.1016/j.neuropharm.2006.09.005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17070873  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17070873'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17070873" class="external text external">17070873</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:33713638  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:33713638'" tppabs="https://api.semanticscholar.org/CorpusID:33713638" class="external text external">33713638</a>.</cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite id="CITEREFZhuWangDonovanJiang2008" class="citation journal cs1">Zhu, Hao-Jie; Wang, Jun-Sheng; Donovan, Jennifer L.; Jiang, Yan; Gibson, Bryan B.; DeVane, C. Lindsay; Markowitz, John S. (January 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pubmed/?term=P-glycoprotein+modafinil  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pubmed/?term=P-glycoprotein+modafinil'" tppabs="https://www.ncbi.nlm.nih.gov/pubmed/?term=P-glycoprotein+modafinil" class="external text external">"Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein"</a>. <i>European Journal of Pharmacology</i>. <b>578</b> (2–3): 148–158. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejphar.2007.09.035  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejphar.2007.09.035'" tppabs="https://doi.org/10.1016%2Fj.ejphar.2007.09.035" class="external text external">10.1016/j.ejphar.2007.09.035</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659508  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659508'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659508" class="external text external">2659508</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17963743  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17963743'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17963743" class="external text external">17963743</a><span class="reference-accessdate">. Retrieved <span class="nowrap">December 4,</span> 2019</span>.</cite></span></li><li id="cite_note-Hardman-62"> <span id="mw-reference-text-cite_note-Hardman-62" class="mw-reference-text"><cite id="CITEREFGilmanGoodmanHardmanLimbird2001" class="citation book cs1">Gilman A, Goodman LS, Hardman JG, Limbird LE (2001). <i>Goodman &amp; Gilman's the pharmacological basis of therapeutics</i>. New York: McGraw-Hill. p.<span>&nbsp;</span>1984. ISBN<span>&nbsp;</span><bdi>978-0-07-135469-1</bdi>.</cite></span></li><li id="cite_note-SchwertnerKong2005-63"> <span id="mw-reference-text-cite_note-SchwertnerKong2005-63" class="mw-reference-text"><cite id="CITEREFSchwertnerKong2005" class="citation journal cs1">Schwertner HA, Kong SB (March 2005). <a href="javascript:if(confirm('https://zenodo.org/record/1259161  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1259161'" tppabs="https://zenodo.org/record/1259161" class="external text external">"Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography"</a>. <i>Journal of Pharmaceutical and Biomedical Analysis</i>. <b>37</b> (3): 475–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpba.2004.11.014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpba.2004.11.014'" tppabs="https://doi.org/10.1016%2Fj.jpba.2004.11.014" class="external text external">10.1016/j.jpba.2004.11.014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15740906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15740906'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15740906" class="external text external">15740906</a>.</cite></span></li><li id="cite_note-WongWang1998-64"> <span id="mw-reference-text-cite_note-WongWang1998-64" class="mw-reference-text"><cite id="CITEREFWongWangHartmanSimcoe1998" class="citation journal cs1">Wong, Y. Nancy; Wang, Lixia; Hartman, Linda; Simcoe, Donna; Chen, Yusong; Laughton, Watson; Eldon, Richard; Markland, Colin; Grebow, Peter (1998). "Comparison of the Single-Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers". <i>The Journal of Clinical Pharmacology</i>. <b>38</b> (10): 971–978. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1552-4604.1998.tb04395.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1552-4604.1998.tb04395.x'" tppabs="https://doi.org/10.1002%2Fj.1552-4604.1998.tb04395.x" class="external text external">10.1002/j.1552-4604.1998.tb04395.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0091-2700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0091-2700'" tppabs="https://www.worldcat.org/issn/0091-2700" class="external text external">0091-2700</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9807980  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9807980'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9807980" class="external text external">9807980</a>.</cite></span></li><li id="cite_note-Robertson2002-65"> <span id="mw-reference-text-cite_note-Robertson2002-65" class="mw-reference-text"><cite id="CITEREFRobertsonHellriegelAroraNelson2002" class="citation journal cs1">Robertson P, Hellriegel ET, Arora S, Nelson M (January 2002). "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers". <i>Clinical Pharmacology and Therapeutics</i>. <b>71</b> (1): 46–56. doi:<a href="javascript:if(confirm('https://doi.org/10.1067%2Fmcp.2002.121217  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1067%2Fmcp.2002.121217'" tppabs="https://doi.org/10.1067%2Fmcp.2002.121217" class="external text external">10.1067/mcp.2002.121217</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11823757  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11823757'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11823757" class="external text external">11823757</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:21552865  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:21552865'" tppabs="https://api.semanticscholar.org/CorpusID:21552865" class="external text external">21552865</a>.</cite></span></li><li id="cite_note-LolandMereu2012-66"> <span id="mw-reference-text-cite_note-LolandMereu2012-66" class="mw-reference-text"><cite id="CITEREFLolandMereuOkunolaCao2012" class="citation journal cs1">Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH (September 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742" class="external text external">"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse"</a>. <i>Biological Psychiatry</i>. <b>72</b> (5): 405–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.biopsych.2012.03.022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.biopsych.2012.03.022'" tppabs="https://doi.org/10.1016%2Fj.biopsych.2012.03.022" class="external text external">10.1016/j.biopsych.2012.03.022</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413742" class="external text external">3413742</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22537794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22537794'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22537794" class="external text external">22537794</a>.</cite></span></li><li id="cite_note-pmid9549666-67"> <span id="mw-reference-text-cite_note-pmid9549666-67" class="mw-reference-text"><cite id="CITEREFWongKingLaughtonMcCormick1998" class="citation journal cs1">Wong YN, King SP, Laughton WB, McCormick GC, Grebow PE (March 1998). "Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers". <i>Journal of Clinical Pharmacology</i>. <b>38</b> (3): 276–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1552-4604.1998.tb04425.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1552-4604.1998.tb04425.x'" tppabs="https://doi.org/10.1002%2Fj.1552-4604.1998.tb04425.x" class="external text external">10.1002/j.1552-4604.1998.tb04425.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9549666  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9549666'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9549666" class="external text external">9549666</a>.</cite></span></li><li id="cite_note-isbn0-9626523-7-7-68"> <span id="mw-reference-text-cite_note-isbn0-9626523-7-7-68" class="mw-reference-text"><cite id="CITEREFBaselt,_Randall_C.2008" class="citation book cs1">Baselt, Randall C. (2008). <i>Disposition of Toxic Drugs and Chemicals in Man</i>. Foster City, CA: Biomedical Publications. pp.<span>&nbsp;</span>1152–1153. ISBN<span>&nbsp;</span><bdi>978-0-9626523-7-0</bdi>.</cite></span></li><li id="cite_note-DesignerTryp-69"> <span id="mw-reference-text-cite_note-DesignerTryp-69" class="mw-reference-text"><cite id="CITEREFSpratleyHayesGeerCooper2005" class="citation journal cs1">Spratley TK, Hayes PA, Geer LC, Cooper SD, McKibben TD (2005). <a href="javascript:if(confirm('http://www.erowid.org/library/periodicals/microgram/microgram_journal_2005-1.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.erowid.org/library/periodicals/microgram/microgram_journal_2005-1.pdf#page=54'" tppabs="http://www.erowid.org/library/periodicals/microgram/microgram_journal_2005-1.pdf#page=54" class="external text external">"Analytical Profiles for Five "Designer" Tryptamines"</a> <span class="cs1-format">(PDF)</span>. <i>Microgram Journal</i>. <b>3</b> (1–2): 54–68.</cite></span></li><li id="cite_note-RTUK_Modafinil-70"> <span id="mw-reference-text-cite_note-RTUK_Modafinil-70" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.reagent-tests.uk/blog/modafinil-reaction-with-the-froehde-reagent-and-others/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.reagent-tests.uk/blog/modafinil-reaction-with-the-froehde-reagent-and-others/'" tppabs="http://www.reagent-tests.uk/blog/modafinil-reaction-with-the-froehde-reagent-and-others/" class="external text external">"Modafinil reaction with the Froehde reagent and others"</a>. Reagent Tests UK. December 13, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">December 18,</span> 2015</span>.</cite></span></li><li id="cite_note-De_RisiFerraro2008-71"> <span id="mw-reference-text-cite_note-De_RisiFerraro2008-71" class="mw-reference-text"><cite id="CITEREFDe_RisiFerraroPolliniTanganelli2008" class="citation journal cs1">De Risi C, Ferraro L, Pollini GP, Tanganelli S, Valente F, Veronese AC (December 2008). "Efficient synthesis and biological evaluation of two modafinil analogues". <i>Bioorganic &amp; Medicinal Chemistry</i>. <b>16</b> (23): 9904–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bmc.2008.10.027  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bmc.2008.10.027'" tppabs="https://doi.org/10.1016%2Fj.bmc.2008.10.027" class="external text external">10.1016/j.bmc.2008.10.027</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18954992  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18954992'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18954992" class="external text external">18954992</a>.</cite></span></li><li id="cite_note-Ballas-72"> <span id="mw-reference-text-cite_note-Ballas-72" class="mw-reference-text"><cite id="CITEREFBallasKimBaldassanoHoeh2002" class="citation journal cs1">Ballas CA, Kim D, Baldassano CF, Hoeh N (July 2002). "Modafinil: past, present and future". <i>Expert Review of Neurotherapeutics</i>. <b>2</b> (4): 449–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F14737175.2.4.449  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F14737175.2.4.449'" tppabs="https://doi.org/10.1586%2F14737175.2.4.449" class="external text external">10.1586/14737175.2.4.449</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19810941  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19810941'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19810941" class="external text external">19810941</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:32939239  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:32939239'" tppabs="https://api.semanticscholar.org/CorpusID:32939239" class="external text external">32939239</a>.</cite></span></li><li id="cite_note-73"> <span id="mw-reference-text-cite_note-73" class="mw-reference-text"><cite id="CITEREFHealy2013" class="citation news cs1">Healy M (May 2, 2013). <a href="javascript:if(confirm('http://articles.latimes.com/2013/may/02/science/la-sci-stay-awake-drug-modafinil-booming-20130502  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://articles.latimes.com/2013/may/02/science/la-sci-stay-awake-drug-modafinil-booming-20130502'" tppabs="http://articles.latimes.com/2013/may/02/science/la-sci-stay-awake-drug-modafinil-booming-20130502" class="external text external">"Use of wake-up drug modafinil takes off, spurred by untested uses – Los Angeles Times"</a>. <i>LA Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 31,</span> 2013</span>.</cite></span></li><li id="cite_note-74"> <span id="mw-reference-text-cite_note-74" class="mw-reference-text"><cite id="CITEREFKesselheimMyersSolomonWinkelmayer2012" class="citation journal cs1">Kesselheim AS, Myers JA, Solomon DH, Winkelmayer WC, Levin R, Avorn J (February 21, 2012).  Alessi-Severini S (ed.). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698" class="external text external">"The prevalence and cost of unapproved uses of top-selling orphan drugs"</a>. <i>PLOS ONE</i>. <b>7</b> (2): e31894. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2012PLoSO...731894K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2012PLoSO...731894K'" tppabs="https://ui.adsabs.harvard.edu/abs/2012PLoSO...731894K" class="external text external">2012PLoSO...731894K</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0031894  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0031894'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0031894" class="external text external">10.1371/journal.pone.0031894</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283698" class="external text external">3283698</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22363762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22363762'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22363762" class="external text external">22363762</a>.</cite></span></li><li id="cite_note-75"> <span id="mw-reference-text-cite_note-75" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html'" tppabs="http://www.bizjournals.com/philadelphia/stories/2006/03/27/daily13.html" class="external text external">"Cephalon gets six-month Provigil patent extension"</a>. Philadelphia Business Journal. March 28, 2006<span class="reference-accessdate">. Retrieved <span class="nowrap">July 21,</span> 2007</span>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.drugpatentwatch.com/ultimate/preview/patent/index.php?query=RE37516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.drugpatentwatch.com/ultimate/preview/patent/index.php?query=RE37516'" tppabs="http://www.drugpatentwatch.com/ultimate/preview/patent/index.php?query=RE37516" class="external text external">"Details for Patent: RE37516"</a>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.prescriptionaccess.org/lawsuitssettlements/current_lawsuits?id=0024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prescriptionaccess.org/lawsuitssettlements/current_lawsuits?id=0024'" tppabs="http://www.prescriptionaccess.org/lawsuitssettlements/current_lawsuits?id=0024" class="external text external">"Prescription Access Litigation (PAL) Project<span>&nbsp;</span>:: Prescription Access Litigation (PAL) Project<span>&nbsp;</span>:: Lawsuits &amp; Settlements<span>&nbsp;</span>:: Current Lawsuits"</a>. Prescriptionaccess.org<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/514  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/514'" tppabs="http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/514" class="external text external">"Document 514<span>&nbsp;</span>:: APOTEX, INC. v. CEPHALON, INC. et al"</a>. Pennsylvania Eastern District Court<span>&nbsp;</span>:: US Federal District Courts Cases<span>&nbsp;</span>:: Justia. October 31, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-url_Justia-79"> <span id="mw-reference-text-cite_note-url_Justia-79" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/513'" tppabs="http://law.justia.com/cases/federal/district-courts/pennsylvania/paedce/2:2006cv02768/205626/513" class="external text external">"Document 513<span>&nbsp;</span>:: APOTEX, INC. v. CEPHALON, INC. et al"</a>. Pennsylvania Eastern District Court<span>&nbsp;</span>:: US Federal District Courts Cases<span>&nbsp;</span>:: Justia. October 31, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-80"> <span id="mw-reference-text-cite_note-80" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.sec.gov/Archives/edgar/data/873364/000104746909001690/a2190556z10-k.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.sec.gov/Archives/edgar/data/873364/000104746909001690/a2190556z10-k.htm'" tppabs="https://www.sec.gov/Archives/edgar/data/873364/000104746909001690/a2190556z10-k.htm" class="external text external">"Cephalon Inc., SEC 10K 2008 disclosure"</a>. February 23, 2009. pp.<span>&nbsp;</span>9–10<span class="reference-accessdate">. Retrieved <span class="nowrap">August 29,</span> 2009</span>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.bloomberg.com/apps/news?pid=20601103&sid=arNEtMSU7D9s  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/apps/news?pid=20601103&sid=arNEtMSU7D9s'" tppabs="https://www.bloomberg.com/apps/news?pid=20601103&sid=arNEtMSU7D9s" class="external text external">"CVS, Rite Aid Sue Cephalon Over Generic Provigil"</a>. Bloomberg News. August 21, 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">August 29,</span> 2009</span>.</cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.mondaq.com/article.asp?articleid=71906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mondaq.com/article.asp?articleid=71906'" tppabs="http://www.mondaq.com/article.asp?articleid=71906" class="external text external">"Canada IP Year in Review 2008"</a>. January 1, 2009.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100424223342/http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100424223342/http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html'" tppabs="https://web.archive.org/web/20100424223342/http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html" class="external text external">"Shire v. Canada"</a>. Archived from <a href="javascript:if(confirm('http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html'" tppabs="http://reports.fja-cmf.gc.ca/eng/2008/2008fc538/2008fc538.html" class="external text external">the original</a> on April 24, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">August 29,</span> 2009</span>.</cite></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120305081801/http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120305081801/http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex'" tppabs="https://web.archive.org/web/20120305081801/http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex" class="external text external">"Cephalon Sues Apotex"</a>. Zacks.com. August 20, 2010. Archived from <a href="javascript:if(confirm('http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex'" tppabs="http://www.zacks.com/stock/news/39048/Cephalon+Sues+Apotex" class="external text external">the original</a> on March 5, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text">"<cite class="citation web cs1"><a href="javascript:if(confirm('http://www.thefreelibrary.com/U.S.+Federal+Trade+Commission+Clears+Teva\'s+Acquisition+of+Cephalon.-a0268983036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.thefreelibrary.com/U.S.+Federal+Trade+Commission+Clears+Teva\'s+Acquisition+of+Cephalon.-a0268983036'" tppabs="http://www.thefreelibrary.com/U.S.+Federal+Trade+Commission+Clears+Teva's+Acquisition+of+Cephalon.-a0268983036" class="external text external">"U.S. Federal Trade Commission Clears Teva's Acquisition of Cephalon"</a>. Business Wire. October 7, 2011. <q>Teva will also grant non-exclusive U.S. rights to an undisclosed company to market modafinil tablets, the generic version of Provigil(R), which had annual brand sales in the U.S. of approximately $1.1<span>&nbsp;</span>billion</q></cite></span></li><li id="cite_note-url_Par_Pharmaceutical-86"> <span id="mw-reference-text-cite_note-url_Par_Pharmaceutical-86" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.prnewswire.com/news-releases/par-pharmaceutical-acquires-three-generic-products-from-teva-pharmaceuticals-132044783.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.prnewswire.com/news-releases/par-pharmaceutical-acquires-three-generic-products-from-teva-pharmaceuticals-132044783.html'" tppabs="http://www.prnewswire.com/news-releases/par-pharmaceutical-acquires-three-generic-products-from-teva-pharmaceuticals-132044783.html" class="external text external">"Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals"</a>. <i>Press Release</i>. PRNewswire. October 18, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFLarson_E2010" class="citation news cs1">Larson E (November 19, 2010). <a href="javascript:if(confirm('https://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html'" tppabs="https://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html" class="external text external">"Cephalon Loses U.K. Bid to Halt Mylan, Orchid Generic-Drug Sales"</a>. bloomberg LP. <a href="javascript:if(confirm('https://web.archive.org/web/20101125113021/http://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20101125113021/http://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html'" tppabs="https://web.archive.org/web/20101125113021/http://www.bloomberg.com/news/2010-11-19/cephalon-loses-u-k-bid-to-halt-mylan-orchid-generic-drug-sales.html" class="external text external">Archived</a> from the original on November 25, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">January 28,</span> 2019</span>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.usdoj.gov/dea/illegal_internet.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.usdoj.gov/dea/illegal_internet.html'" tppabs="http://www.usdoj.gov/dea/illegal_internet.html" class="external text external">"Is It Illegal to Obtain Controlled Substances From the Internet?"</a>. United States Drug Enforcement Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">July 21,</span> 2007</span>.</cite></span></li><li id="cite_note-89"> <span id="mw-reference-text-cite_note-89" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm'" tppabs="http://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_26.htm" class="external text external">"USC 201 Section 1301.26 Exemptions from import or export requirements for personal medical use"</a>. United States Department of Justice. March 24, 1997.</cite></span></li><li id="cite_note-90"> <span id="mw-reference-text-cite_note-90" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20080223233036/https://www.fda.gov/opacom/laws/pdma.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080223233036/https://www.fda.gov/opacom/laws/pdma.html'" tppabs="https://web.archive.org/web/20080223233036/https://www.fda.gov/opacom/laws/pdma.html" class="external text external">"Prescription Drug Marketing Act of 1987 (PDMA), PL 100-293"</a>. U.S. Food and Drug Administration. Archived from <a href="javascript:if(confirm('https://www.fda.gov/opacom/laws/pdma.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/opacom/laws/pdma.html'" tppabs="https://www.fda.gov/opacom/laws/pdma.html" class="external text external">the original</a> on February 23, 2008.</cite></span></li><li id="cite_note-91"> <span id="mw-reference-text-cite_note-91" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM164556.pdfFDA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM164556.pdfFDA'" tppabs="https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM164556.pdfFDA" class="external text external">"Letter to Cephalon 01/03/2002"</a>. January 3, 2002<span class="reference-accessdate">. Retrieved <span class="nowrap">July 4,</span> 2012</span>.</cite></span></li><li id="cite_note-92"> <span id="mw-reference-text-cite_note-92" class="mw-reference-text">"Cephalon executives have repeatedly said that they do not condone off-label use of Provigil, but in 2002 the company was reprimanded by the FDA for distributing marketing materials that presented the drug as a remedy for tiredness, "decreased activity" and other supposed ailments. In 2008, Cephalon paid $425m and pleaded guilty to a federal criminal charge relating to its promotion of off-label uses for Provigil and two other drugs." <a href="javascript:if(confirm('http://www.law360.com/articles/127434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.law360.com/articles/127434'" tppabs="http://www.law360.com/articles/127434" class="external free external">http://www.law360.com/articles/127434</a> </span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite id="CITEREFAnne_Zieger2008" class="citation web cs1">Anne Zieger (September 30, 2008). <a href="javascript:if(confirm('https://web.archive.org/web/20130524152915/http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130524152915/http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30'" tppabs="https://web.archive.org/web/20130524152915/http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30" class="external text external">"Cephalon settlement requires physician payments to be disclosed"</a>. <i>Fierce Healthcare</i>. Archived from <a href="javascript:if(confirm('http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30'" tppabs="http://www.fiercehealthcare.com/story/cephalon-settlement-requires-physician-payments-be-disclosed/2008-09-30" class="external text external">the original</a> on May 24, 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">June 7,</span> 2012</span>.</cite></span></li><li id="cite_note-94"> <span id="mw-reference-text-cite_note-94" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20181205061404/http://samr.cfda.gov.cn/WS01/CL0844/94735.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20181205061404/http://samr.cfda.gov.cn/WS01/CL0844/94735.html'" tppabs="https://web.archive.org/web/20181205061404/http://samr.cfda.gov.cn/WS01/CL0844/94735.html" class="external text external">"食品药品监管总局 公安部 国家卫生计生委关于公布麻醉药品和精神药品品种目录的通知"</a>. China Food and Drug Administration. Archived from <a href="javascript:if(confirm('http://samr.cfda.gov.cn/WS01/CL0844/94735.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://samr.cfda.gov.cn/WS01/CL0844/94735.html'" tppabs="http://samr.cfda.gov.cn/WS01/CL0844/94735.html" class="external text external">the original</a> on December 5, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">November 11,</span> 2013</span>.</cite></span></li><li id="cite_note-95"> <span id="mw-reference-text-cite_note-95" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.gov.cn/flfg/2007-03/13/content_549406.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.gov.cn/flfg/2007-03/13/content_549406.htm'" tppabs="http://www.gov.cn/flfg/2007-03/13/content_549406.htm" class="external text external">"处方管理办法（原卫生部令第53号）"</a>. <i>中国政府网</i> (in Chinese).</cite></span></li><li id="cite_note-96"> <span id="mw-reference-text-cite_note-96" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://hn.people.com.cn/n2/2017/1218/c374564-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://hn.people.com.cn/n2/2017/1218/c374564-3'" tppabs="http://hn.people.com.cn/n2/2017/1218/c374564-3" class="external text external">"莫达非尼国内获批上市 威尔曼新药拥有量再上台阶"</a>. <i>people.cn</i> (in Chinese). December 18, 2017.</cite></span></li><li id="cite_note-97"> <span id="mw-reference-text-cite_note-97" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ncd.mhlw.go.jp/img/en/total.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ncd.mhlw.go.jp/img/en/total.pdf'" tppabs="http://www.ncd.mhlw.go.jp/img/en/total.pdf" class="external text external">"List of psychotropics"</a> <span class="cs1-format">(PDF)</span><span class="reference-accessdate">. Retrieved <span class="nowrap">May 24,</span> 2019</span>.</cite></span></li><li id="cite_note-98"> <span id="mw-reference-text-cite_note-98" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20150515002556/http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150515002556/http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html'" tppabs="https://web.archive.org/web/20150515002556/http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html" class="external text external">"モダフィニルの向精神薬への指定"</a>. Archived from <a href="javascript:if(confirm('http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html'" tppabs="http://www.fukushihoken.metro.tokyo.jp/kenkou/iyaku/sonota/shitei_m/moda.html" class="external text external">the original</a> on May 15, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">January 17,</span> 2017</span>.</cite></span></li><li id="cite_note-99"> <span id="mw-reference-text-cite_note-99" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20190209124042/http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190209124042/http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/'" tppabs="https://web.archive.org/web/20190209124042/http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/" class="external text external">"医疗用医薬品の添付文书情报-モディオダール锭１００ｍｇ"</a>. <i>独立行政法人 医薬品医疗机器総合机构</i> (in Japanese). Archived from <a href="javascript:if(confirm('http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/'" tppabs="http://www.info.pmda.go.jp/go/pack/1179047F1022_2_15/" class="external text external">the original</a> on February 9, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">February 9,</span> 2019</span>.</cite></span></li><li id="cite_note-100"> <span id="mw-reference-text-cite_note-100" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20190121010916/https://medicallaw.exblog.jp/20422896/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190121010916/https://medicallaw.exblog.jp/20422896/'" tppabs="https://web.archive.org/web/20190121010916/https://medicallaw.exblog.jp/20422896/" class="external text external">"モダフィニル密輸で逮捕された歯科医師，ダイエットに使用と供述（報道）"</a>. <i>Medicallaw.exblog.jp</i>. Archived from <a href="javascript:if(confirm('https://medicallaw.exblog.jp/20422896/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medicallaw.exblog.jp/20422896/'" tppabs="https://medicallaw.exblog.jp/20422896/" class="external text external">the original</a> on January 21, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">January 20,</span> 2019</span>.</cite></span></li><li id="cite_note-101"> <span id="mw-reference-text-cite_note-101" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://hayabusa3.5ch.net/test/read.cgi/news/1391949369/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hayabusa3.5ch.net/test/read.cgi/news/1391949369/'" tppabs="https://hayabusa3.5ch.net/test/read.cgi/news/1391949369/" class="external text external">"向精神薬をインドから密輸入した男を逮捕"</a>. <i>Hayabusa3.5ch.net</i><span class="reference-accessdate">. Retrieved <span class="nowrap">January 20,</span> 2019</span>.</cite></span></li><li id="cite_note-102"> <span id="mw-reference-text-cite_note-102" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://anad.gov.ro/web/wp-content/uploads/2017/10/LISTA-2018-web.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://anad.gov.ro/web/wp-content/uploads/2017/10/LISTA-2018-web.pdf'" tppabs="http://anad.gov.ro/web/wp-content/uploads/2017/10/LISTA-2018-web.pdf" class="external text external">"AGENȚIA NAȚIONALĂ ANTI-DOPING"</a> <span class="cs1-format">(PDF)</span>.</cite></span></li><li id="cite_note-103"> <span id="mw-reference-text-cite_note-103" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://base.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=142882;fld=134;dst=4294967295;rnd=0.8965571122244;from=141820-563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://base.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=142882;fld=134;dst=4294967295;rnd=0.8965571122244;from=141820-563'" tppabs="http://base.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=142882;fld=134;dst=4294967295;rnd=0.8965571122244;from=141820-563" class="external text external">"Data"</a> <span class="cs1-format">(PDF)</span>. <i>base.consultant.ru</i>.</cite></span></li><li id="cite_note-104"> <span id="mw-reference-text-cite_note-104" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.legislation.gov.au/Details/F2018L00168  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.legislation.gov.au/Details/F2018L00168'" tppabs="https://www.legislation.gov.au/Details/F2018L00168" class="external text external">"Poisons Standard March 2018"</a>. Legislation.gov.au<span class="reference-accessdate">. Retrieved <span class="nowrap">January 20,</span> 2019</span>.</cite></span></li><li id="cite_note-105"> <span id="mw-reference-text-cite_note-105" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20190807175859/https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20190807175859/https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf'" tppabs="https://web.archive.org/web/20190807175859/https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf" class="external text external">"Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika"</a> <span class="cs1-format">(PDF)</span>. Archived from <a href="javascript:if(confirm('https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf'" tppabs="https://lakemedelsverket.se/upload/lvfs/konsoliderade/LVFS_2011_10_konsoliderad_tom_HSLF-FS_2019_7.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on August 7, 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">August 7,</span> 2019</span>.</cite></span></li><li id="cite_note-106"> <span id="mw-reference-text-cite_note-106" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110706181716/http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110706181716/http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html'" tppabs="https://web.archive.org/web/20110706181716/http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html" class="external text external">"Regulations Amending the Food and Drug Regulations (1184 — Modafinil)"</a>. <i>Canada Gazette</i>. <b>140</b> (20). March 26, 2005. Archived from <a href="javascript:if(confirm('http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html#REF1'" tppabs="http://gazette.gc.ca/archives/p1/2005/2005-03-26/html/reg5-eng.html#REF1" class="external text external">the original</a> <span class="cs1-format">(– <sup><a href="javascript:if(confirm('https://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3ARegulations+Amending+the+Food+and+Drug+Regulations+%281184+%E2%80%94+Modafinil%29&as_publication=%5B%5BCanada+Gazette%5D%5D&as_ylo=&as_yhi=&btnG=Search  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3ARegulations+Amending+the+Food+and+Drug+Regulations+%281184+%E2%80%94+Modafinil%29&as_publication=%5B%5BCanada+Gazette%5D%5D&as_ylo=&as_yhi=&btnG=Search'" tppabs="https://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3ARegulations+Amending+the+Food+and+Drug+Regulations+%281184+%E2%80%94+Modafinil%29&as_publication=%5B%5BCanada+Gazette%5D%5D&as_ylo=&as_yhi=&btnG=Search" class="external text external">Scholar search</a></sup>)</span> on July 6, 2011.</cite></span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.finlex.fi/fi/laki/alkup/2009/20091095  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.finlex.fi/fi/laki/alkup/2009/20091095'" tppabs="http://www.finlex.fi/fi/laki/alkup/2009/20091095" class="external text external">"Lääkealan turvallisuus- ja kehittämiskeskuksen päätöslääkeluettelosta"</a>. <i>Finlex.fi</i>. 2009.</cite></span></li><li id="cite_note-108"> <span id="mw-reference-text-cite_note-108" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20070713135452/http://www.cofepris.gob.mx/pyp/estpsic/es.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070713135452/http://www.cofepris.gob.mx/pyp/estpsic/es.htm'" tppabs="https://web.archive.org/web/20070713135452/http://www.cofepris.gob.mx/pyp/estpsic/es.htm" class="external text external">"Estupefacientes y Psicotrópicos"</a> <span>[</span>Narcotic Drugs and Psychotropic Substances<span>]</span> (in Spanish). Federal Commission for Protection against Health Risks. Archived from <a href="javascript:if(confirm('http://www.cofepris.gob.mx/pyp/estpsic/es.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cofepris.gob.mx/pyp/estpsic/es.htm'" tppabs="http://www.cofepris.gob.mx/pyp/estpsic/es.htm" class="external text external">the original</a> on July 13, 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">July 21,</span> 2007</span>.</cite></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite id="CITEREFSA_Government2003" class="citation web cs1">SA Government (April 10, 2003). <a href="javascript:if(confirm('https://web.archive.org/web/20160422183746/http://saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160422183746/http://saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf'" tppabs="https://web.archive.org/web/20160422183746/http://saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf" class="external text external">"GENERAL REGULATIONS MADE IN TERMS OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965, AS AMENDED Government Notice R510 in Government Gazette 24727 dated 10 April 2003. 22A/16/b; states that although import and export is restricted, possession is not illegal providing that a prescription is present"</a> <span class="cs1-format">(PDF)</span>. Pretoria: SAFLII. Archived from <a href="javascript:if(confirm('http://www.saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf'" tppabs="http://www.saflii.org/za/legis/consol_reg/marsa101o1965rangnr510723.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on April 22, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">November 11,</span> 2016</span>.</cite></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite id="CITEREFMHRA2013" class="citation web cs1">MHRA (April 3, 2013). <a href="javascript:if(confirm('http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con273748.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con273748.pdf'" tppabs="http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con273748.pdf" class="external text external">"MHRA license for Modafinil in UK"</a> <span class="cs1-format">(PDF)</span>. London: MHRA<span class="reference-accessdate">. Retrieved <span class="nowrap">April 3,</span> 2013</span>.</cite></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/modafinil.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/modafinil.html'" tppabs="https://www.drugs.com/international/modafinil.html" class="external text external">"Modafinil – International Brands"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">January 8,</span> 2017</span>.</cite></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><a href="javascript:if(confirm('https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf'" tppabs="https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf" class="external free external">https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf</a></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.cyclingnews.com/news/clinger-given-lifetime-ban-for-second-doping-infraction  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cyclingnews.com/news/clinger-given-lifetime-ban-for-second-doping-infraction'" tppabs="http://www.cyclingnews.com/news/clinger-given-lifetime-ban-for-second-doping-infraction" class="external text external">"Clinger given lifetime ban for second doping infraction"</a>. Cycling News. August 14, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">October 8,</span> 2014</span>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.washingtonpost.com/wp-dyn/content/article/2010/12/24/AR2010122402993.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.washingtonpost.com/wp-dyn/content/article/2010/12/24/AR2010122402993.html'" tppabs="https://www.washingtonpost.com/wp-dyn/content/article/2010/12/24/AR2010122402993.html" class="external text external">"Taurasi tested positive for modafinil"</a>. <i>The Washington Post</i>. December 25, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">December 31,</span> 2013</span>.</cite></span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text"><cite id="CITEREFsport2015" class="citation news cs1">sport, Guardian (November 23, 2015). <a href="javascript:if(confirm('https://www.theguardian.com/sport/2015/nov/23/british-rowers-handed-two-year-bans-doping-violations-sybren-hoogland-timothy-grant  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/sport/2015/nov/23/british-rowers-handed-two-year-bans-doping-violations-sybren-hoogland-timothy-grant'" tppabs="https://www.theguardian.com/sport/2015/nov/23/british-rowers-handed-two-year-bans-doping-violations-sybren-hoogland-timothy-grant" class="external text external">"British rowers handed two-year bans for taking banned substances"</a>. <i>The Guardian</i>.</cite></span></li><li id="cite_note-116"> <span id="mw-reference-text-cite_note-116" class="mw-reference-text"><cite id="CITEREFVoepel_M2011" class="citation web cs1">Voepel M (February 18, 2011). <a href="javascript:if(confirm('http://sports.espn.go.com/wnba/columns/story?columnist=voepel_mechelle&id=6135920  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://sports.espn.go.com/wnba/columns/story?columnist=voepel_mechelle&id=6135920'" tppabs="http://sports.espn.go.com/wnba/columns/story?columnist=voepel_mechelle&id=6135920" class="external text external">"Taurasi: 'I've lost 3 months of my career<span class="cs1-kern-right">'</span>"</a>.</cite></span></li><li id="cite_note-117"> <span id="mw-reference-text-cite_note-117" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120122061356/http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120122061356/http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html'" tppabs="https://web.archive.org/web/20120122061356/http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html" class="external text external">"Bonds Exposed"</a>. <i>Sports Illustrated</i>. March 7, 2006. Archived from <a href="javascript:if(confirm('http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html'" tppabs="http://sportsillustrated.cnn.com/2006/baseball/mlb/03/06/news.excerpt/1.html" class="external text external">the original</a> on January 22, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">July 2,</span> 2011</span>.</cite></span></li><li id="cite_note-118"> <span id="mw-reference-text-cite_note-118" class="mw-reference-text"><cite id="CITEREFJacobsBell2004" class="citation journal cs1">Jacobs I, Bell DG (June 2004). "Effects of acute modafinil ingestion on exercise time to exhaustion". <i>Medicine and Science in Sports and Exercise</i>. <b>36</b> (6): 1078–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1249%2F01.MSS.0000128146.12004.4F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1249%2F01.MSS.0000128146.12004.4F'" tppabs="https://doi.org/10.1249%2F01.MSS.0000128146.12004.4F" class="external text external">10.1249/01.MSS.0000128146.12004.4F</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15179180  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15179180'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15179180" class="external text external">15179180</a>.</cite></span></li><li id="cite_note-119"> <span id="mw-reference-text-cite_note-119" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://abcnews.go.com/Technology/Health/story?id=3408266  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://abcnews.go.com/Technology/Health/story?id=3408266'" tppabs="https://abcnews.go.com/Technology/Health/story?id=3408266" class="external text external">"Super Soldiers? Military Drug New Rage"</a>. ABC News. December 7, 2008.</cite></span></li><li id="cite_note-120"> <span id="mw-reference-text-cite_note-120" class="mw-reference-text"><cite class="citation magazine cs1"><a href="javascript:if(confirm('https://hbr.org/2016/05/like-it-or-not-smart-drugs-are-coming-to-the-office  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hbr.org/2016/05/like-it-or-not-smart-drugs-are-coming-to-the-office'" tppabs="https://hbr.org/2016/05/like-it-or-not-smart-drugs-are-coming-to-the-office" class="external text external">"Like It or Not, "Smart Drugs" Are Coming to the Office"</a>. <i>Harvard Business Review</i>. May 2015.</cite></span></li><li id="cite_note-121"> <span id="mw-reference-text-cite_note-121" class="mw-reference-text"><cite id="CITEREFCadwalladr2015" class="citation news cs1">Cadwalladr, Carole (February 14, 2015). <a href="javascript:if(confirm('https://www.theguardian.com/society/2015/feb/15/students-smart-drugs-higher-grades-adderall-modafinil  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.theguardian.com/society/2015/feb/15/students-smart-drugs-higher-grades-adderall-modafinil'" tppabs="https://www.theguardian.com/society/2015/feb/15/students-smart-drugs-higher-grades-adderall-modafinil" class="external text external">"Students used to take drugs to get high. Now they take them to get higher grades"</a>. <i>The Guardian</i>.</cite></span></li><li id="cite_note-122"> <span id="mw-reference-text-cite_note-122" class="mw-reference-text"><cite id="CITEREFTalbot" class="citation magazine cs1">Talbot, Margaret. <a href="javascript:if(confirm('http://www.newyorker.com/magazine/2009/04/27/brain-gain  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.newyorker.com/magazine/2009/04/27/brain-gain'" tppabs="http://www.newyorker.com/magazine/2009/04/27/brain-gain" class="external text external">"Brain Gain"</a>. <i>The New Yorker</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 9,</span> 2017</span>.</cite></span></li><li id="cite_note-123"> <span id="mw-reference-text-cite_note-123" class="mw-reference-text"><cite id="CITEREFPlotz2003" class="citation news cs1">Plotz, David (August 21, 2003). <a href="javascript:if(confirm('http://www.zeit.de/2003/35/M-Modafinil/komplettansicht  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.zeit.de/2003/35/M-Modafinil/komplettansicht'" tppabs="http://www.zeit.de/2003/35/M-Modafinil/komplettansicht" class="external text external">"Medikamente: 100 Milligramm Arbeitswut"</a>. <i>Die Zeit</i><span class="reference-accessdate">. Retrieved <span class="nowrap">April 9,</span> 2017</span>.</cite></span></li><li id="cite_note-124"> <span id="mw-reference-text-cite_note-124" class="mw-reference-text"><cite id="CITEREFKumar2008" class="citation journal cs1">Kumar R (2008). "Approved and investigational uses of modafinil<span>&nbsp;</span>: an evidence-based review". <i>Drugs</i>. <b>68</b> (13): 1803–39. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200868130-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200868130-00003'" tppabs="https://doi.org/10.2165%2F00003495-200868130-00003" class="external text external">10.2165/00003495-200868130-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18729534  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18729534'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18729534" class="external text external">18729534</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:38542387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:38542387'" tppabs="https://api.semanticscholar.org/CorpusID:38542387" class="external text external">38542387</a>.</cite></span></li><li id="cite_note-Kane_D’Souza_Patkar_Youakim_pp._1475–1481-125"> <span id="mw-reference-text-cite_note-Kane_D’Souza_Patkar_Youakim_pp._1475–1481-125" class="mw-reference-text"><cite id="CITEREFKaneD’SouzaPatkarYouakim2010" class="citation journal cs1">Kane, John M.; D’Souza, Deepak C.; Patkar, Ashwin A.; Youakim, James M.; Tiller, Jane M.; Yang, Ronghua; Keefe, Richard S. E. (August 24, 2010). "Armodafinil as Adjunctive Therapy in Adults With Cognitive Deficits Associated With Schizophrenia". <i>The Journal of Clinical Psychiatry</i>. <b>71</b> (11): 1475–1481. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2Fjcp.09m05950gry  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2Fjcp.09m05950gry'" tppabs="https://doi.org/10.4088%2Fjcp.09m05950gry" class="external text external">10.4088/jcp.09m05950gry</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0160-6689  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0160-6689'" tppabs="https://www.worldcat.org/issn/0160-6689" class="external text external">0160-6689</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20816042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20816042'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20816042" class="external text external">20816042</a>.</cite></span></li><li id="cite_note-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21-126"> <span id="mw-reference-text-cite_note-Andrade_Kisely_Monteiro_Rao_2015_pp._14–21-126" class="mw-reference-text"><cite id="CITEREFAndradeKiselyMonteiroRao2015" class="citation journal cs1">Andrade, Chittaranjan; Kisely, Steve; Monteiro, Ingrid; Rao, Sanjay (2015). <a href="javascript:if(confirm('http://espace.library.uq.edu.au/view/UQ:345290/UQ345290_OA.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://espace.library.uq.edu.au/view/UQ:345290/UQ345290_OA.pdf'" tppabs="http://espace.library.uq.edu.au/view/UQ:345290/UQ345290_OA.pdf" class="external text external">"Antipsychotic augmentation with modafinil or armodafinil for negative symptoms of schizophrenia: Systematic review and meta-analysis of randomized controlled trials"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Psychiatric Research</i>. <b>60</b>: 14–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jpsychires.2014.09.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jpsychires.2014.09.013'" tppabs="https://doi.org/10.1016%2Fj.jpsychires.2014.09.013" class="external text external">10.1016/j.jpsychires.2014.09.013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25306261  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25306261'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25306261" class="external text external">25306261</a>.</cite></span></li><li id="cite_note-Correll_Rubio_Inczedy-Farkas_Birnbaum-127"> <span id="mw-reference-text-cite_note-Correll_Rubio_Inczedy-Farkas_Birnbaum-127" class="mw-reference-text"><cite id="CITEREFCorrellRubioInczedy-FarkasBirnbaum2017" class="citation journal cs1">Correll, Christoph U.; Rubio, Jose M.; Inczedy-Farkas, Gabriella; Birnbaum, Michael L.; Kane, John M.; Leucht, Stefan (June 1, 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320" class="external text external">"Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia"</a>. <i>JAMA Psychiatry</i>. <b>74</b> (7): 675–684. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamapsychiatry.2017.0624  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamapsychiatry.2017.0624'" tppabs="https://doi.org/10.1001%2Fjamapsychiatry.2017.0624" class="external text external">10.1001/jamapsychiatry.2017.0624</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584320" class="external text external">6584320</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28514486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28514486'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28514486" class="external text external">28514486</a>.</cite></span></li><li id="cite_note-urlprovigil.com-128"> <span id="mw-reference-text-cite_note-urlprovigil.com-128" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160304035819/http://provigil.com/media/PDFs/medication_guide.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160304035819/http://provigil.com/media/PDFs/medication_guide.pdf'" tppabs="https://web.archive.org/web/20160304035819/http://provigil.com/media/PDFs/medication_guide.pdf" class="external text external">"Provigil"</a> <span class="cs1-format">(PDF)</span>. <i>Medication Guide</i>. Cephalon, Inc. November 1, 2010. Archived from <a href="javascript:if(confirm('http://provigil.com/media/PDFs/medication_guide.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://provigil.com/media/PDFs/medication_guide.pdf'" tppabs="http://provigil.com/media/PDFs/medication_guide.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on March 4, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">December 31,</span> 2013</span>.</cite></span></li><li id="cite_note-129"> <span id="mw-reference-text-cite_note-129" class="mw-reference-text"><cite id="CITEREFKredlowKeshishianOppenheimerOtto2019" class="citation journal cs1">Kredlow, M. Alexandra; Keshishian, Ani; Oppenheimer, Sarah; Otto, Michael W. (2019). "The Efficacy of Modafinil as a Cognitive Enhancer: A Systematic Review and Meta-Analysis". <i>Journal of Clinical Psychopharmacology</i>. <b>39</b> (5): 455–461. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FJCP.0000000000001085  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FJCP.0000000000001085'" tppabs="https://doi.org/10.1097%2FJCP.0000000000001085" class="external text external">10.1097/JCP.0000000000001085</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0271-0749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0271-0749'" tppabs="https://www.worldcat.org/issn/0271-0749" class="external text external">0271-0749</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31433334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31433334'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31433334" class="external text external">31433334</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:201119084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:201119084'" tppabs="https://api.semanticscholar.org/CorpusID:201119084" class="external text external">201119084</a>.</cite></span></li><li id="cite_note-130"> <span id="mw-reference-text-cite_note-130" class="mw-reference-text"><cite id="CITEREFPortelaRubialesCenteno2011" class="citation journal cs1">Portela MA, Rubiales AS, Centeno C (June 2011). "The use of psychostimulants in cancer patients". <i>Current Opinion in Supportive and Palliative Care</i>. <b>5</b> (2): 164–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FSPC.0b013e3283462ff3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FSPC.0b013e3283462ff3'" tppabs="https://doi.org/10.1097%2FSPC.0b013e3283462ff3" class="external text external">10.1097/SPC.0b013e3283462ff3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21532350  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21532350'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21532350" class="external text external">21532350</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:39218702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:39218702'" tppabs="https://api.semanticscholar.org/CorpusID:39218702" class="external text external">39218702</a>.</cite></span></li><li id="cite_note-Cochrane2015-131"> <span id="mw-reference-text-cite_note-Cochrane2015-131" class="mw-reference-text"><cite id="CITEREFMückeCuhlsPeuckmann-PostMinton2015" class="citation journal cs1">Mücke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L (May 2015). <a href="javascript:if(confirm('http://discovery.ucl.ac.uk/1473387/1/Mucke%20et%20al%202015.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://discovery.ucl.ac.uk/1473387/1/Mucke%20et%20al%202015.pdf'" tppabs="http://discovery.ucl.ac.uk/1473387/1/Mucke%20et%20al%202015.pdf" class="external text external">"Pharmacological treatments for fatigue associated with palliative care"</a> <span class="cs1-format">(PDF)</span>. <i>The Cochrane Database of Systematic Reviews</i>. <b>30</b> (5): CD006788. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD006788.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD006788.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD006788.pub3" class="external text external">10.1002/14651858.CD006788.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483317  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483317'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483317" class="external text external">6483317</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26026155  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26026155'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26026155" class="external text external">26026155</a>.</cite></span></li><li id="cite_note-132"> <span id="mw-reference-text-cite_note-132" class="mw-reference-text"><cite class="citation journal cs1">Ballon, JS; Feifel, D (April 2006). "A systematic review of modafinil: Potential clinical uses and mechanisms of action". <i>The Journal of Clinical Psychiatry</i>. <b>67</b> (4): 554–66. doi:<a href="javascript:if(confirm('https://doi.org/10.4088%2Fjcp.v67n0406  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4088%2Fjcp.v67n0406'" tppabs="https://doi.org/10.4088%2Fjcp.v67n0406" class="external text external">10.4088/jcp.v67n0406</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16669720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16669720'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16669720" class="external text external">16669720</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://web.archive.org/web/20061230144002/http://rxlist.com/cgi/generic2/modafinil_pi.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061230144002/http://rxlist.com/cgi/generic2/modafinil_pi.htm'" tppabs="https://web.archive.org/web/20061230144002/http://rxlist.com/cgi/generic2/modafinil_pi.htm" class="external text external">RxList Patient Information</a> for modafinil users</li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/modafinil  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/modafinil'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/modafinil" class="external text external">"Modafinil"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Stimulants" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Stimulants" style="font-size:114%;margin:0 4em">Stimulants</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Adamantane.htm" tppabs="https://ptable.com/wiki/compounds/A/Adamantane" title="Adamantane">Adamantanes</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Adapromine</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li>Bromantane</li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Adenosine antagonists</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="8-Chlorotheophylline-1.htm" tppabs="https://ptable.com/wiki/compounds/A/8-Chlorotheophylline" title="8-Chlorotheophylline">8-Chlorotheophylline</a></li>
<li>8-Cyclopentyltheophylline</li>
<li>8-Phenyltheophylline</li>
<li><a href="Aminophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminophylline" title="Aminophylline">Aminophylline</a></li>
<li><a href="Caffeine.htm" tppabs="https://ptable.com/wiki/compounds/A/Caffeine" title="Caffeine">Caffeine</a></li>
<li>CGS-15943</li>
<li>Dimethazan</li>
<li><a href="Paraxanthine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paraxanthine" title="Paraxanthine">Paraxanthine</a></li>
<li>SCH-58261</li>
<li><a href="Theobromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Theobromine" title="Theobromine">Theobromine</a></li>
<li><a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">Theophylline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alkylamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cyclopentamine</li>
<li>Cypenamine</li>
<li>Cyprodenate</li>
<li><a href="Heptaminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Heptaminol" title="Heptaminol">Heptaminol</a></li>
<li>Isometheptene</li>
<li>Levopropylhexedrine</li>
<li>Methylhexaneamine</li>
<li><a href="Octodrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Octodrine" title="Octodrine">Octodrine</a></li>
<li>Propylhexedrine</li>
<li><a href="Tuaminoheptane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tuaminoheptane" title="Tuaminoheptane">Tuaminoheptane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ampakines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CX-516</li>
<li>CX-546</li>
<li>CX-614</li>
<li>CX-691</li>
<li>CX-717</li>
<li>IDRA-21</li>
<li>LY-404,187</li>
<li>LY-503,430</li>
<li>Nooglutyl</li>
<li>Org 26576</li>
<li>PEPA</li>
<li>S-18986</li>
<li>Sunifiram</li>
<li>Unifiram</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benocyclidine</li>
<li>Dieticyclidine</li>
<li>Esketamine</li>
<li>Eticyclidine</li>
<li>Gacyclidine</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Phencyclamine</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li><a href="Rolicyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolicyclidine" title="Rolicyclidine">Rolicyclidine</a></li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li>
<li>Tiletamine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Benzazepines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>6-Br-APB</li>
<li>SKF-77434</li>
<li>SKF-81297</li>
<li>SKF-82958</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cathinones</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluoromethcathinone</li>
<li>3,4-DMMC</li>
<li>4-BMC</li>
<li>4-CMC</li>
<li>4-Methylbuphedrone</li>
<li>4-Methylcathinone</li>
<li>4-MEAP</li>
<li>4-Methylpentedrone</li>
<li><a href="Amfepramone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amfepramone" title="Amfepramone">Amfepramone</a></li>
<li>Benzedrone</li>
<li>Buphedrone</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Butylone</li>
<li><a href="Cathinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathinone" title="Cathinone">Cathinone</a></li>
<li>Dimethylcathinone</li>
<li>Ethcathinone</li>
<li>Ethylone</li>
<li>Flephedrone</li>
<li>Hexedrone</li>
<li>Isoethcathinone</li>
<li>Mephedrone</li>
<li>Methcathinone</li>
<li>Methedrone</li>
<li>Methylenedioxycathinone</li>
<li>Methylone</li>
<li>Mexedrone</li>
<li>N-Ethylbuphedrone</li>
<li>N-Ethylhexedrone</li>
<li>Pentedrone</li>
<li>Pentylone</li>
<li>Phthalimidopropiophenone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">Cholinergics</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>A-84,543</li>
<li>A-366,833</li>
<li>ABT-202</li>
<li>ABT-418</li>
<li>AR-R17779</li>
<li>Altinicline</li>
<li><a href="Anabasine.htm" tppabs="https://ptable.com/wiki/compounds/A/Anabasine" title="Anabasine">Anabasine</a></li>
<li><a href="Arecoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Arecoline" title="Arecoline">Arecoline</a></li>
<li>Bradanicline</li>
<li><a href="Cotinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cotinine" title="Cotinine">Cotinine</a></li>
<li><a href="Cytisine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytisine" title="Cytisine">Cytisine</a></li>
<li>Dianicline</li>
<li>Epibatidine</li>
<li>Epiboxidine</li>
<li>GTS-21</li>
<li>Ispronicline</li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li>PHA-543,613</li>
<li>PNU-120,596</li>
<li>PNU-282,987</li>
<li>Pozanicline</li>
<li>Rivanicline</li>
<li>Sazetidine A</li>
<li>SIB-1553A</li>
<li>SSR-180,711</li>
<li>TC-1698</li>
<li>TC-1827</li>
<li>TC-2216</li>
<li>Tebanicline</li>
<li>UB-165</li>
<li><a href="Varenicline.htm" tppabs="https://ptable.com/wiki/compounds/A/Varenicline" title="Varenicline">Varenicline</a></li>
<li>WAY-317,538</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Convulsants</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anatoxin-a.htm" tppabs="https://ptable.com/wiki/compounds/A/Anatoxin-a" title="Anatoxin-a">Anatoxin-a</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Bicuculline  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Bicuculline'" tppabs="https://ptable.com/wiki/compounds/A/Bicuculline" title="Bicuculline">Bicuculline</a></li>
<li>DMCM</li>
<li><a href="Flurothyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Flurothyl" title="Flurothyl">Flurothyl</a></li>
<li>Gabazine</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haldol" title="Haldol" class="mw-redirect">Haldol</a></li>
<li><a href="Pentylenetetrazol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentylenetetrazol" title="Pentylenetetrazol">Pentetrazol</a></li>
<li><a href="Picrotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Picrotoxin" title="Picrotoxin">Picrotoxin</a></li>
<li><a href="Strychnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Strychnine" title="Strychnine">Strychnine</a></li>
<li>Thujone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Eugeroics</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Armodafinil</li>
<li>CRL-40,940</li>
<li>CRL-40,941</li>
<li>Fluorenol</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Oxazolines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="4-Methylaminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Methylaminorex" title="4-Methylaminorex">4-Methylaminorex</a></li>
<li><a href="Aminorex.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminorex" title="Aminorex">Aminorex</a></li>
<li>Clominorex</li>
<li>Cyclazodone</li>
<li>Fenozolone</li>
<li>Fluminorex</li>
<li><a href="Pemoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemoline" title="Pemoline">Pemoline</a></li>
<li>Thozalinone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenethylamines</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-(4-Methylphenyl)-2-aminobutane</li>
<li>1-Methylamino-1-(3,4-methylenedioxyphenyl)propane</li>
<li>2-Fluoroamphetamine</li>
<li>2-Fluoromethamphetamine</li>
<li><a href="2-Hydroxyphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Hydroxyphenethylamine" title="2-Hydroxyphenethylamine" class="mw-redirect">2-OH-PEA</a></li>
<li>2-Phenyl-3-aminobutane</li>
<li>2,3-MDA</li>
<li>3-Fluoroamphetamine</li>
<li>3-Fluoroethamphetamine</li>
<li>3-Methoxyamphetamine</li>
<li>3-Methylamphetamine</li>
<li>4-Fluoroamphetamine</li>
<li>4-Fluoromethamphetamine</li>
<li>4-MA</li>
<li>4-MMA</li>
<li>4-MTA</li>
<li>6-FNE</li>
<li>AL-1095</li>
<li>Alfetamine</li>
<li>a-Ethylphenethylamine</li>
<li>Amfecloral</li>
<li>Amfepentorex</li>
<li>Amidephrine</li>
<li>2-Amino-1,2-dihydronaphthalene</li>
<li>2-Aminoindane</li>
<li>5-(2-Aminopropyl)indole</li>
<li><a href="2-Aminotetralin.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Aminotetralin" title="2-Aminotetralin">2-Aminotetralin</a></li>
<li>Acridorex</li>
<li><a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">Amphetamine</a> (<a href="Dextroamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextroamphetamine" title="Dextroamphetamine">Dextroamphetamine</a>, <a href="Levoamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levoamphetamine" title="Levoamphetamine">Levoamphetamine</a>)</li>
<li>Amphetaminil</li>
<li><a href="Arbutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arbutamine" title="Arbutamine">Arbutamine</a></li>
<li><a href="Β-Methylphenethylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%92-Methylphenethylamine" title="Β-Methylphenethylamine">β-Methylphenethylamine</a></li>
<li>β-Phenylmethamphetamine</li>
<li>Benfluorex</li>
<li><a href="Benzphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzphetamine" title="Benzphetamine">Benzphetamine</a></li>
<li>BDB</li>
<li>BOH</li>
<li>3-Benzhydrylmorpholine</li>
<li>BPAP</li>
<li>Camfetamine</li>
<li><a href="Cathine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cathine" title="Cathine">Cathine</a></li>
<li><a href="Chlorphentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphentermine" title="Chlorphentermine">Chlorphentermine</a></li>
<li>Cilobamine</li>
<li>Cinnamedrine</li>
<li><a href="Clenbuterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clenbuterol" title="Clenbuterol">Clenbuterol</a></li>
<li>Clobenzorex</li>
<li>Cloforex</li>
<li><a href="Clortermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clortermine" title="Clortermine">Clortermine</a></li>
<li>Cypenamine</li>
<li><small>D</small>-Deprenyl</li>
<li>Denopamine</li>
<li><a href="Dimethoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimethoxyamphetamine" title="Dimethoxyamphetamine">Dimethoxyamphetamine</a></li>
<li>Dimethylamphetamine</li>
<li><a href="Dobutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dobutamine" title="Dobutamine">Dobutamine</a></li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">DOPA</a> (Dextrodopa, <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">Levodopa</a>)</li>
<li><a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">Dopamine</a></li>
<li>Dopexamine</li>
<li><a href="L-DOPS.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPS" title="L-DOPS" class="mw-redirect">Droxidopa</a></li>
<li>EBDB</li>
<li><a href="Ephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ephedrine" title="Ephedrine">Ephedrine</a></li>
<li><a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">Epinephrine</a></li>
<li>Epinine</li>
<li>Etafedrine</li>
<li>Ethylnorepinephrine</li>
<li>Etilamfetamine</li>
<li>Etilefrine</li>
<li>Famprofazone</li>
<li>Fencamfamin</li>
<li>Fencamine</li>
<li><a href="Fenethylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenethylline" title="Fenethylline">Fenethylline</a></li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a> (<a href="Dexfenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexfenfluramine" title="Dexfenfluramine">Dexfenfluramine</a>, Levofenfluramine)</li>
<li><a href="Fenproporex.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenproporex" title="Fenproporex">Fenproporex</a></li>
<li>Feprosidnine</li>
<li>Fludorex</li>
<li>Formetorex</li>
<li>Furfenorex</li>
<li>Gepefrine</li>
<li>Hexapradol</li>
<li>HMMA</li>
<li>Hordenine</li>
<li>4-Hydroxyamphetamine</li>
<li>5-Iodo-2-aminoindane</li>
<li>Ibopamine</li>
<li>Indanylamphetamine</li>
<li>Iofetamine</li>
<li><a href="Isoetarine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoetarine" title="Isoetarine">Isoetarine</a></li>
<li><a href="Isoprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoprenaline" title="Isoprenaline">Isoprenaline</a></li>
<li><a href="Selegiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Selegiline" title="Selegiline"><small>L</small>-Deprenyl</a> (Selegiline)</li>
<li>Lefetamine</li>
<li><a href="Lisdexamfetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisdexamfetamine" title="Lisdexamfetamine">Lisdexamfetamine</a></li>
<li>Lophophine</li>
<li>MBDB</li>
<li><a href="3,4-Methylenedioxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Methylenedioxyamphetamine" title="3,4-Methylenedioxyamphetamine">MDA (tenamfetamine)</a></li>
<li>MDBU</li>
<li>MDEA</li>
<li><a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA (midomafetamine)</a></li>
<li>MDMPEA</li>
<li>MDOH</li>
<li>MDPR</li>
<li>MDPEA</li>
<li>Mefenorex</li>
<li><a href="Mephentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephentermine" title="Mephentermine">Mephentermine</a></li>
<li>Metanephrine</li>
<li><a href="Metaraminol.htm" tppabs="https://ptable.com/wiki/compounds/A/Metaraminol" title="Metaraminol">Metaraminol</a></li>
<li>Mesocarb</li>
<li><a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Methamphetamine</a> (<a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">Dextromethamphetamine</a>, Levomethamphetamine)</li>
<li><a href="Methoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxamine" title="Methoxamine">Methoxamine</a></li>
<li>Methoxyphenamine</li>
<li>MMA</li>
<li>Methoxyphenamine</li>
<li>MMDA</li>
<li>MMDMA</li>
<li>MMMA</li>
<li>Morforex</li>
<li>N,alpha-Diethylphenylethylamine</li>
<li>N,N-Dimethylphenethylamine</li>
<li>Naphthylamphetamine</li>
<li>Nisoxetine</li>
<li>Norepinephrine</li>
<li><a href="Norfenefrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Norfenefrine" title="Norfenefrine">Norfenefrine</a></li>
<li>Norfenfluramine</li>
<li>Normetanephrine</li>
<li><a href="L-Norpseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/L-Norpseudoephedrine" title="L-Norpseudoephedrine"><small>L</small>-Norpseudoephedrine</a></li>
<li>Octopamine</li>
<li><a href="Orciprenaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Orciprenaline" title="Orciprenaline">Orciprenaline</a></li>
<li>Ortetamine</li>
<li>Oxifentorex</li>
<li>Oxilofrine</li>
<li>PBA</li>
<li>PCA</li>
<li>PCMA</li>
<li>PHA</li>
<li>Pentorex</li>
<li><span class="new">Phenatine</span></li>
<li>Phenpromethamine</li>
<li><a href="Phentermine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phentermine" title="Phentermine">Phentermine</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine">Phenylalanine</a></li>
<li><a href="Phenylephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylephrine" title="Phenylephrine">Phenylephrine</a></li>
<li><a href="Phenylpropanolamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylpropanolamine" title="Phenylpropanolamine">Phenylpropanolamine</a></li>
<li><a href="Pholedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pholedrine" title="Pholedrine">Pholedrine</a></li>
<li>PIA</li>
<li><a href="Para-Methoxyamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Para-Methoxyamphetamine" title="Para-Methoxyamphetamine">PMA</a></li>
<li>PMEA</li>
<li>PMMA</li>
<li>PPAP</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Propylamphetamine</li>
<li><a href="Pseudoephedrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pseudoephedrine" title="Pseudoephedrine">Pseudoephedrine</a></li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="Salbutamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Salbutamol" title="Salbutamol">Salbutamol</a> (Levosalbutamol)</li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Solriamfetol</li>
<li><a href="Synephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Synephrine" title="Synephrine">Synephrine</a></li>
<li>Theodrenaline</li>
<li>Tiflorex</li>
<li><a href="Tranylcypromine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tranylcypromine" title="Tranylcypromine">Tranylcypromine</a></li>
<li><a href="Tyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyramine" title="Tyramine">Tyramine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">Tyrosine</a></li>
<li>Xylopropamine</li>
<li>Zylofuramine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Phenylmorpholines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>3-Fluorophenmetrazine</li>
<li>Fenbutrazate</li>
<li>Fenmetramide</li>
<li>G-130</li>
<li>Manifaxine</li>
<li>Morazone</li>
<li>Morforex</li>
<li>Oxaflozane</li>
<li>PD-128,907</li>
<li><a href="Phendimetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phendimetrazine" title="Phendimetrazine">Phendimetrazine</a></li>
<li><a href="Phenmetrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenmetrazine" title="Phenmetrazine">Phenmetrazine</a></li>
<li>2-Phenyl-3,6-dimethylmorpholine</li>
<li>Pseudophenmetrazine</li>
<li>Radafaxine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperazine" title="Piperazine">Piperazines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2C-B-BZP</li>
<li>3C-PEP</li>
<li><a href="Benzylpiperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylpiperazine" title="Benzylpiperazine">BZP</a></li>
<li>CM156</li>
<li>DBL-583</li>
<li>GBR-12783</li>
<li>GBR-12935</li>
<li>GBR-13069</li>
<li>GBR-13098</li>
<li>GBR-13119</li>
<li>MeOPP</li>
<li>MBZP</li>
<li>oMPP</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Piperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperidine" title="Piperidine">Piperidines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-Benzyl-4-(2-(diphenylmethoxy)ethyl)piperidine</li>
<li>2-Benzylpiperidine</li>
<li>2-Methyl-3-phenylpiperidine</li>
<li>3,4-Dichloromethylphenidate</li>
<li><a href="4-Benzylpiperidine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Benzylpiperidine" title="4-Benzylpiperidine">4-Benzylpiperidine</a></li>
<li>4-Fluoromethylphenidate</li>
<li>4-Methylmethylphenidate</li>
<li>Desoxypipradrol</li>
<li>Difemetorex</li>
<li>Diphenylpyraline</li>
<li>Ethylnaphthidate</li>
<li>Ethylphenidate</li>
<li>Methylnaphthidate</li>
<li>Isopropylphenidate</li>
<li>JZ-IV-10</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a> (Dexmethylphenidate)</li>
<li>Nocaine</li>
<li>Phacetoperane</li>
<li>Pipradrol</li>
<li>Propylphenidate</li>
<li>SCH-5472</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Pyrrolidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrrolidine" title="Pyrrolidine">Pyrrolidines</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-Diphenylmethylpyrrolidine</li>
<li>4-Cl-PVP</li>
<li>5-DBFPV</li>
<li>α-PPP</li>
<li>α-PBP</li>
<li>α-PCYP</li>
<li>α-PHiP</li>
<li>α-PHP</li>
<li>α-PHPP</li>
<li>α-PVP</li>
<li>α-PVT</li>
<li>Diphenylprolinol</li>
<li>DMPVP</li>
<li>FPOP</li>
<li>FPVP</li>
<li>MDPPP</li>
<li>MDPBP</li>
<li>MPBP</li>
<li>MPHP</li>
<li>MPPP</li>
<li>MOPVP</li>
<li>MOPPP</li>
<li>Indapyrophenidone</li>
<li>MDPV</li>
<li>Naphyrone</li>
<li>PEP</li>
<li>Picilorex</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Racetams</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Oxiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxiracetam" title="Oxiracetam">Oxiracetam</a></li>
<li>Phenylpiracetam</li>
<li>Phenylpiracetam hydrazide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-fluorotropacocaine</li>
<li>4'-Fluorococaine</li>
<li>Altropane (IACFT)</li>
<li>Brasofensine</li>
<li>CFT (WIN 35,428)</li>
<li>β-CIT (RTI-55)</li>
<li><a href="Cocaethylene.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaethylene" title="Cocaethylene">Cocaethylene</a></li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dichloropane (RTI-111)</li>
<li>Difluoropine</li>
<li>FE-β-CPPIT</li>
<li>FP-β-CPPIT</li>
<li>Ioflupane (<sup>123</sup>I)</li>
<li>Norcocaine</li>
<li>PIT</li>
<li>PTT</li>
<li>RTI-31</li>
<li>RTI-32</li>
<li>RTI-51</li>
<li>RTI-112</li>
<li>RTI-113</li>
<li>RTI-120</li>
<li>RTI-121 (IPCIT)</li>
<li>RTI-126</li>
<li>RTI-150</li>
<li>RTI-177</li>
<li>RTI-229</li>
<li>RTI-336</li>
<li>RTI-354</li>
<li>RTI-371</li>
<li>RTI-386</li>
<li>Salicylmethylecgonine</li>
<li>Tesofensine</li>
<li>Troparil (β-CPT, WIN 35,065-2)</li>
<li>Tropoxane</li>
<li>WF-23</li>
<li>WF-33</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tryptamines</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>4-HO-αMT</li>
<li>4-Methyl-αET</li>
<li>4-Methyl-αMT</li>
<li>5-Chloro-αMT</li>
<li>5-Fluoro-αMT</li>
<li>5-MeO-αET</li>
<li>5-MeO-αMT</li>
<li>5-MeO-DIPT</li>
<li>6-Fluoro-αMT</li>
<li>7-Methyl-αET</li>
<li>αET</li>
<li>αMT</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>2-MDP</li>
<li>3,3-Diphenylcyclobutanamine</li>
<li>Amfonelic acid</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="Amiphenazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiphenazole" title="Amiphenazole">Amiphenazole</a></li>
<li>Atipamezole</li>
<li><a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine</a></li>
<li><a href="Bemegride.htm" tppabs="https://ptable.com/wiki/compounds/A/Bemegride" title="Bemegride">Bemegride</a></li>
<li>Benzydamine</li>
<li>BTQ</li>
<li>BTS 74,398</li>
<li>Centanafadine</li>
<li>Ciclazindol</li>
<li>Clofenciclan</li>
<li>Cropropamide</li>
<li>Crotetamide</li>
<li>D-161</li>
<li>Desipramine</li>
<li>Diclofensine</li>
<li>Dimethocaine</li>
<li>Efaroxan</li>
<li><a href="Etamivan.htm" tppabs="https://ptable.com/wiki/compounds/A/Etamivan" title="Etamivan">Etamivan</a></li>
<li>Fenisorex</li>
<li>Fenpentadiol</li>
<li>Gamfexine</li>
<li>Gilutensin</li>
<li>GSK1360707F</li>
<li>GYKI-52895</li>
<li>Hexacyclonate</li>
<li>Idazoxan</li>
<li>Indanorex</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>Lazabemide</li>
<li>Leptacline</li>
<li>Lomevactone</li>
<li>LR-5182</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Meclofenoxate</li>
<li>Medifoxamine</li>
<li>Mefexamide</li>
<li>Methamnetamine</li>
<li>Methastyridone</li>
<li>Methiopropamine</li>
<li>Naphthylaminopropane</li>
<li>Nefopam</li>
<li><a href="Nikethamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nikethamide" title="Nikethamide">Nikethamide</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>O-2172</li>
<li>Oxaprotiline</li>
<li>PNU-99,194</li>
<li>PRC200-SS</li>
<li><a href="Rasagiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li>Rauwolscine</li>
<li><a href="Rubidium_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Rubidium_chloride" title="Rubidium chloride">Rubidium chloride</a></li>
<li>Setazindol</li>
<li>Tametraline</li>
<li>Tandamine</li>
<li>Thiopropamine</li>
<li>Thiothinone</li>
<li>Trazium</li>
<li>UH-232</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="font-style:italic"><div>ATC code: N06B</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Monoamine_reuptake_inhibitors" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Monoamine_reuptake_inhibitors" style="font-size:114%;margin:0 4em">Monoamine reuptake inhibitors</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>DAT</abbr><br><small>(<abbr>DRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Piperazines:</i> DBL-583</li>
<li>GBR-12783</li>
<li>GBR-12935</li>
<li>GBR-13069</li>
<li>GBR-13098</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Piperidines:</i> 4-Fluoropethidine</li>
<li>Benocyclidine (BTCP)</li>
<li>Desoxypipradrol</li>
<li>Dexmethylphenidate</li>
<li>Difemetorex</li>
<li>Ethylphenidate</li>
<li>HDMP-28</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">Pethidine (meperidine)</a></li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Pipradrol</li>
<li><a href="Tenocyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tenocyclidine" title="Tenocyclidine">Tenocyclidine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Pyrrolidines:</i> Diphenylprolinol</li>
<li>MDPV</li>
<li>Naphyrone</li>
<li>Prolintane</li>
<li>Pyrovalerone</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tropanes:</i> Altropane</li>
<li><a href="Benzatropine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzatropine" title="Benzatropine">Benzatropine (benztropine)</a></li>
<li>Brasofensine</li>
<li>CFT</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dichloropane</li>
<li>Difluoropine</li>
<li>Etybenzatropine (ethybenztropine)</li>
<li>FE-β-CPPIT</li>
<li>FP-β-CPPIT</li>
<li>Ioflupane (<sup>123</sup>I)</li>
<li>RTI-55</li>
<li>RTI-112</li>
<li>RTI-113</li>
<li>RTI-121</li>
<li>RTI-126</li>
<li>RTI-150</li>
<li>RTI-177</li>
<li>RTI-229</li>
<li>RTI-336</li>
<li>Tesofensine</li>
<li>Troparil</li>
<li>Tropoxane</li>
<li>WF-11</li>
<li>WF-23</li>
<li>WF-31</li>
<li>WF-33</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> <a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Amifitadine</li>
<li>Armodafinil</li>
<li>Amfonelic acid</li>
<li><a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li>Ansofaxine</li>
<li>BTQ</li>
<li>BTS 74,398</li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li><i>Chaenomeles speciosa</i></li>
<li>Ciclazindol</li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>Dimethocaine</li>
<li>Diphenylpyraline</li>
<li>Dizocilpine (MK-801)</li>
<li>DOV-102,677</li>
<li>DOV-216,303</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Ephenidine</li>
<li>Esketamine</li>
<li>EXP-561</li>
<li>Fencamfamin</li>
<li>Fezolamine</li>
<li>Fluorenol</li>
<li>GYKI-52895</li>
<li>Indatraline</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Lefetamine</li>
<li>Levophacetoperane</li>
<li>Liafensine</li>
<li>LR-5182</li>
<li>Manifaxine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Medifoxamine</li>
<li>Mesocarb</li>
<li>Metaphit</li>
<li>MIN-117 (WF-516)</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li>Nefopam</li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>NS-2359</li>
<li>O-2172</li>
<li>Oroxylin A</li>
<li>Perafensine</li>
<li>Pridefine</li>
<li>Radafaxine</li>
<li><a href="Rimcazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimcazole" title="Rimcazole">Rimcazole</a></li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Solriamfetol</li>
<li>Tametraline</li>
<li>Tedatioxetine</li>
<li><a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">Tripelennamine</a></li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>NET</abbr><br><small>(<abbr>NRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Selective norepinephrine reuptake inhibitors:</i> Amedalin</li>
<li><a href="Alseroxylon.htm" tppabs="https://ptable.com/wiki/compounds/A/Alseroxylon" title="Alseroxylon">Alseroxylon</a></li>
<li>Ciclazindol</li>
<li>Daledalin</li>
<li>Edivoxetine</li>
<li>Esreboxetine</li>
<li>Lortalamine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Nisoxetine</li>
<li><a href="Reboxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reboxetine" title="Reboxetine">Reboxetine</a></li>
<li>Talopram</li>
<li>Talsupram</li>
<li>Tandamine</li>
<li>Teniloxazine</li>
<li>Viloxazine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Norepinephrine–dopamine reuptake inhibitors:</i> <a href="Amineptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amineptine" title="Amineptine">Amineptine</a></li>
<li><a href="Bupropion.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupropion" title="Bupropion">Bupropion</a></li>
<li>Fencamine</li>
<li>Fencamfamin</li>
<li>Hydroxybupropion</li>
<li>Lefetamine</li>
<li>Levophacetoperane</li>
<li>LR-5182</li>
<li>Manifaxine</li>
<li><a href="Methylphenidate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylphenidate" title="Methylphenidate">Methylphenidate</a></li>
<li><a href="Nomifensine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nomifensine" title="Nomifensine">Nomifensine</a></li>
<li>O-2172</li>
<li>Radafaxine</li>
<li>Solriamfetol</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine reuptake inhibitors:</i> <a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine (tomoxetine)</a></li>
<li><span class="new">BTS-54505</span></li>
<li>CP-39,332</li>
<li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Eclanamine</li>
<li>Levomilnacipran</li>
<li><span class="new">McN-5652</span></li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>N-Methyl-PPPA</li>
<li><span class="new">Nafenodone</span></li>
<li>PPPA</li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li>
<li><span class="new">WY-45233</span></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine–dopamine reuptake inhibitors:</i> 3,3-Diphenylcyclobutanamine</li>
<li>Amifitadine</li>
<li>Ansofaxine</li>
<li>Bicifadine</li>
<li>Brasofensine</li>
<li>Centanafadine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>DOV-102677</li>
<li>DOV-216303</li>
<li>EXP-561</li>
<li>Fezolamine</li>
<li>HDMP-28</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>JZ-IV-10</li>
<li>Liafensine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Naphyrone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Nefopam</li>
<li>NS-2359</li>
<li>Perafensine</li>
<li>PRC200</li>
<li>Pridefine</li>
<li><span class="new">SEP-228431</span></li>
<li><span class="new">SEP-228432</span></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tedatioxetine</li>
<li>Tesofensine</li>
<li><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a> (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tricyclic antidepressants:</i> <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li>Butriptyline</li>
<li>Cianopramine</li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li>Desipramine</li>
<li>Dosulepin (dothiepin)</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Lofepramine</li>
<li>Melitracen</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li>
<li><a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tetracyclic antidepressants:</i> <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="Maprotiline.htm" tppabs="https://ptable.com/wiki/compounds/A/Maprotiline" title="Maprotiline">Maprotiline</a></li>
<li><a href="Mianserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mianserin" title="Mianserin">Mianserin</a></li>
<li>Oxaprotiline</li>
<li>Setiptiline</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> Antihistamines (e.g., <a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">brompheniramine</a>, <a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">chlorphenamine</a>, <a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">pheniramine</a>, <a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">tripelennamine</a>)</li>
<li>Antipsychotics (e.g., <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a> (e.g., <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>)</li>
<li>Dopexamine</li>
<li>Ephenidine</li>
<li><i>Ginkgo biloba</i></li>
<li>Indeloxazine</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Opioids (e.g., desmetramadol, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine (meperidine)</a>, tapentadol, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>, <a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">levorphanol</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>SERT</abbr><br><small>(<abbr>SRIs</abbr>)</small></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Selective serotonin reuptake inhibitors:</i> Alaproclate</li>
<li><span class="new">Centpropazine</span></li>
<li>Cericlamine</li>
<li><a href="Citalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Citalopram" title="Citalopram">Citalopram</a></li>
<li>Dapoxetine</li>
<li>Desmethylcitalopram</li>
<li>Didesmethylcitalopram</li>
<li><a href="Escitalopram.htm" tppabs="https://ptable.com/wiki/compounds/A/Escitalopram" title="Escitalopram">Escitalopram</a></li>
<li>Femoxetine</li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">Fluvoxamine</a></li>
<li>Indalpine</li>
<li>Ifoxetine</li>
<li>Norfluoxetine</li>
<li>Omiloxetine</li>
<li>Panuramine</li>
<li><a href="Paroxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Paroxetine" title="Paroxetine">Paroxetine</a></li>
<li>PIM-35</li>
<li>Pirandamine</li>
<li>RTI-353</li>
<li>Seproxetine</li>
<li><a href="Sertraline.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertraline" title="Sertraline">Sertraline</a></li>
<li><a href="Zimelidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zimelidine" title="Zimelidine">Zimelidine</a></li></ul>

<ul><li><i>Selective serotonin reuptake inhibitors and serotonin receptor modulators:</i> Etoperidone</li>
<li>Litoxetine</li>
<li>Lubazodone</li>
<li><span class="new">LY-393558</span></li>
<li>SB-649915</li>
<li>TGBA01AD</li>
<li><a href="Trazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Trazodone" title="Trazodone">Trazodone</a></li>
<li>Vilazodone</li>
<li>Vortioxetine</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine reuptake inhibitors:</i> <a href="Atomoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atomoxetine" title="Atomoxetine">Atomoxetine (tomoxetine)</a></li>
<li>Bicifadine</li>
<li><span class="new">BTS-54505</span></li>
<li><span class="new">CP-39332</span></li>
<li>Desvenlafaxine</li>
<li><a href="Duloxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Duloxetine" title="Duloxetine">Duloxetine</a></li>
<li>Eclanamine</li>
<li>Levomilnacipran</li>
<li><span class="new">McN-5652</span></li>
<li><a href="Milnacipran.htm" tppabs="https://ptable.com/wiki/compounds/A/Milnacipran" title="Milnacipran">Milnacipran</a></li>
<li>N-Methyl-PPPA</li>
<li>PPPA</li>
<li>Tofenacin</li>
<li><a href="Venlafaxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Venlafaxine" title="Venlafaxine">Venlafaxine</a></li>
<li><span class="new">WY-45233</span></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Serotonin–norepinephrine–dopamine reuptake inhibitors:</i> 3,3-Diphenylcyclobutanamine</li>
<li>Amifitadine</li>
<li>Ansofaxine</li>
<li>Bicifadine</li>
<li>Brasofensine</li>
<li>Centanafadine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Dasotraline</li>
<li>Desmethylsertraline</li>
<li><span class="new">Desmethylsibutramine</span></li>
<li>Diclofensine</li>
<li><span class="new">Didesmethylsibutramine</span></li>
<li>DOV-102677</li>
<li>DOV-216303</li>
<li>EXP-561</li>
<li>Fezolamine</li>
<li>HDMP-28</li>
<li>Indatraline</li>
<li>JNJ-7925476</li>
<li>JZ-IV-10</li>
<li>Liafensine</li>
<li><a href="Mazindol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mazindol" title="Mazindol">Mazindol</a></li>
<li>Naphyrone</li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Nefopam</li>
<li>NS-2359</li>
<li>Perafensine</li>
<li>PRC200</li>
<li>Pridefine</li>
<li><span class="new">SEP-228431</span></li>
<li><span class="new">SEP-228432</span></li>
<li><a href="Sibutramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sibutramine" title="Sibutramine">Sibutramine</a></li>
<li>Tedatioxetine</li>
<li>Tesofensine</li>
<li><a href="Tropane.htm" tppabs="https://ptable.com/wiki/compounds/A/Tropane" title="Tropane">Tropanes</a> (e.g., <a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">cocaine</a>)</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Tricyclic antidepressants:</i> <a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li>Cianopramine</li>
<li><a href="Clomipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomipramine" title="Clomipramine">Clomipramine</a></li>
<li>Cyanodothiepin</li>
<li>Desipramine</li>
<li>Dosulepin (dothiepin)</li>
<li><a href="Doxepin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxepin" title="Doxepin">Doxepin</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li>
<li>Lofepramine</li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li>Pipofezine</li>
<li><a href="Protriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Protriptyline" title="Protriptyline">Protriptyline</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Others:</i> <span class="new">A-80426</span></li>
<li><a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li>Antihistamines (e.g., <a href="Brompheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Brompheniramine" title="Brompheniramine">brompheniramine</a>, <a href="Chlorphenamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorphenamine" title="Chlorphenamine">chlorphenamine</a>, <a href="Dimenhydrinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimenhydrinate" title="Dimenhydrinate">dimenhydrinate</a>, <a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">diphenhydramine</a>, <a href="Mepyramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepyramine" title="Mepyramine">mepyramine (pyrilamine)</a>, <a href="Pheniramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pheniramine" title="Pheniramine">pheniramine</a>, <a href="Tripelennamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tripelennamine" title="Tripelennamine">tripelennamine</a>)</li>
<li>Antipsychotics (e.g., <a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">loxapine</a>, <a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">ziprasidone</a>)</li>
<li><a href="Arylcyclohexylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arylcyclohexylamine" title="Arylcyclohexylamine">Arylcyclohexylamines</a> (e.g., 3-MeO-PCP, esketamine, <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, methoxetamine, <a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">phencyclidine</a>)</li>
<li><a href="Cyclobenzaprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclobenzaprine" title="Cyclobenzaprine">Cyclobenzaprine</a></li>
<li>Delucemine</li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li>Dextrorphan</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>Medifoxamine</li>
<li>Mesembrine</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>MIN-117 (WF-516)</li>
<li>N-Me-5-HT</li>
<li>Opioids (e.g., <a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">dextropropoxyphene</a>, <a href="Methadone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methadone" title="Methadone">methadone</a>, <a href="Pethidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pethidine" title="Pethidine">pethidine (meperidine)</a>, <a href="Levorphanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Levorphanol" title="Levorphanol">levorphanol</a>, tapentadol, <a href="Tramadol.htm" tppabs="https://ptable.com/wiki/compounds/A/Tramadol" title="Tramadol">tramadol</a>)</li>
<li>Roxindole</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>VMATs</abbr></th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>Amphetamines (e.g., <a href="Amphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphetamine" title="Amphetamine">amphetamine</a>, <a href="Methamphetamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Methamphetamine" title="Methamphetamine">methamphetamine</a>, <a href="MDMA.htm" tppabs="https://ptable.com/wiki/compounds/A/MDMA" title="MDMA">MDMA</a>)</li>
<li><span class="new">APP</span></li>
<li><span class="new">AZIK</span></li>
<li>Bietaserpine</li>
<li><a href="Deserpidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Deserpidine" title="Deserpidine">Deserpidine</a></li>
<li>Deutetrabenazine</li>
<li>Dihydrotetrabenazine</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>GBR-12935</li>
<li><span class="new">GZ-793A</span></li>
<li>Ibogaine</li>
<li><a href="Ketanserin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketanserin" title="Ketanserin">Ketanserin</a></li>
<li>Lobeline</li>
<li><span class="new">Methoxytetrabenazine</span></li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><a href="Rose_bengal.htm" tppabs="https://ptable.com/wiki/compounds/A/Rose_bengal" title="Rose bengal">Rose bengal</a></li>
<li><a href="Tetrabenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a></li>
<li>Valbenazine</li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine (GBR-12909)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>DAT enhancers:</i> <a href="Luteolin.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteolin" title="Luteolin">Luteolin</a></li></ul>

<ul><li><i>DAT modulators:</i> <i>Agonist-like:</i> SoRI-9804</li>
<li><span class="new">SoRI-20040</span>; <i>Antagonist-like:</i> SoRI-20041</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><small><i><b>See also:</b> Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins</i></small></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Dopamine_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Dopamine_receptor_modulators" style="font-size:114%;margin:0 4em">Dopamine receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">D<sub>1</sub>-like</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Benzazepines</i>: 6-Br-APB</li>
<li><a href="Fenoldopam.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenoldopam" title="Fenoldopam">Fenoldopam</a></li>
<li>SKF-38,393</li>
<li>SKF-77,434</li>
<li>SKF-81,297</li>
<li>SKF-82,958</li>
<li>SKF-83,959</li>
<li>Trepipam</li>
<li><span class="new">Zelandopam</span></li></ul>

<ul><li><i>Ergolines</i>: <a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li>CY-208,243</li>
<li>Dihydroergocryptine</li>
<li><span class="new">LEK-8829</span></li>
<li><a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">Pergolide</a></li>
<li><a href="Terguride.htm" tppabs="https://ptable.com/wiki/compounds/A/Terguride" title="Terguride">Terguride</a></li></ul>

<ul><li><i>Dihydrexidine derivatives</i>: A-77636</li>
<li>A-86929</li>
<li>Adrogolide (ABT-431, DAS-431)</li>
<li>Dihydrexidine</li>
<li>Dinapsoline</li>
<li>Dinoxyline</li>
<li>Doxanthrine</li></ul>

<ul><li><i>Phenethylamines</i>: <span class="new">BCO-001</span></li>
<li>Deoxyepinephrine (N-methyldopamine, epinine)</li>
<li>Dopexamine</li>
<li>Etilevodopa</li>
<li>Ibopamine</li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li>
<li>Melevodopa</li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li>
<li><span class="new">XP21279</span></li></ul>

<ul><li><i>Others</i>: A-68930</li>
<li><a href="Apomorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li><span class="new">Isocorypalmine</span></li>
<li>Nuciferine</li>
<li><span class="new">PF-6649751</span></li>
<li><span class="new">PF 6669571</span></li>
<li>Propylnorapomorphine</li>
<li>Rotigotine</li>
<li>SKF-89,145</li>
<li><span class="new">SKF-89,626</span></li>
<li>Stepholidine</li>
<li><a href="Tetrahydropalmatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Typical antipsychotics</i>: Butaclamol</li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chlorprothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li>
<li><a href="Flupentixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Flupentixol" title="Flupentixol">Flupentixol (flupenthixol)</a> (+melitracen)</li>
<li><a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li><a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">Loxapine</a></li>
<li><a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">Perphenazine</a> (+amitriptyline)</li>
<li><span class="new">Pifluthixol</span></li>
<li><a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a> (+tranylcypromine)</li>
<li><a href="Zuclopenthixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a></li></ul>

<ul><li><i>Atypical antipsychotics</i>: Asenapine</li>
<li>Clorotepine</li>
<li>Clotiapine</li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li>DHA-clozapine</li>
<li>Fluperlapine</li>
<li>Iloperidone</li>
<li>Norclozapine</li>
<li><span class="new">Norquetiapine</span></li>
<li><a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">Olanzapine</a> (++fluoxetine)</li>
<li><a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">Paliperidone</a></li>
<li><a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">Quetiapine</a></li>
<li><a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">Risperidone</a></li>
<li><span class="new">Tefludazine</span></li>
<li>Zicronapine</li>
<li><a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li>
<li>Zotepine</li></ul>

<ul><li><i>Others</i>: <span class="new">Berupipam</span></li>
<li>Ecopipam</li>
<li><a href="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethoxycarbonyl-2-ethoxy-1%2C2-dihydroquinoline" title="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline">EEDQ</a></li>
<li>Metitepine (methiothepin)</li>
<li><span class="new">Odapipam</span></li>
<li>Perlapine</li>
<li>SCH-23390</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">D<sub>2</sub>-like</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Adamantanes</i>: <a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="Memantine.htm" tppabs="https://ptable.com/wiki/compounds/A/Memantine" title="Memantine">Memantine</a></li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>

<ul><li><i>Aminotetralins</i>: 5-OH-DPAT</li>
<li>7-OH-DPAT</li>
<li>8-OH-PBZI</li>
<li>Rotigotine</li>
<li>UH-232</li></ul>

<ul><li><i>Ergolines</i>: <a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="Cabergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li>Dihydroergocryptine</li>
<li>Epicriptine</li>
<li>Ergocornine</li>
<li>Lergotrile</li>
<li><a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="Lysergic_acid_diethylamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysergic_acid_diethylamide" title="Lysergic acid diethylamide">LSD</a></li>
<li><a href="Pergolide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pergolide" title="Pergolide">Pergolide</a></li>
<li><a href="Terguride.htm" tppabs="https://ptable.com/wiki/compounds/A/Terguride" title="Terguride">Terguride</a></li></ul>

<ul><li><i>Dihydrexidine derivatives</i>: 2-OH-NPA</li>
<li>Ciladopa</li>
<li>Dihydrexidine</li>
<li>Dinoxyline</li>
<li><span class="new">N,N-Propyldihydrexidine</span></li></ul>

<ul><li><i>Phenethylamines</i>: Deoxyepinephrine (N-methyldopamine, epinine)</li>
<li>Dopexamine</li>
<li>Etilevodopa</li>
<li>Ibopamine</li>
<li><a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA"><small>L</small>-DOPA (levodopa)</a></li>
<li><a href="Phenylalanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenylalanine" title="Phenylalanine"><small>L</small>-Phenylalanine</a></li>
<li><a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine"><small>L</small>-Tyrosine</a></li>
<li>Melevodopa</li>
<li><span class="new">XP21279</span></li></ul>

<ul><li><i>Atypical antipsychotics</i>: Alentemol (U-66444B)</li>
<li><a href="Aripiprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Aripiprazole" title="Aripiprazole">Aripiprazole</a> (+sertraline)</li>
<li>Aripiprazole lauroxil</li>
<li>Bifeprunox</li>
<li>Brexpiprazole</li>
<li>Brilaroxazine</li>
<li>Cariprazine</li>
<li>F-15063</li>
<li>Lumateperone</li>
<li>Norclozapine</li></ul>

<ul><li><i>Others</i>: 3-PPP</li>
<li>A-412997</li>
<li>ABT-670</li>
<li>ABT-724</li>
<li><a href="Adrafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrafinil" title="Adrafinil">Adrafinil</a></li>
<li>Aplindore</li>
<li><a href="Apomorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li>Arketamine</li>
<li>Armodafinil</li>
<li>BP-897</li>
<li>Captodiame</li>
<li>CP-226,269</li>
<li>Dizocilpine</li>
<li>Esketamine</li>
<li>Flibanserin</li>
<li>GSK-789,472</li>
<li><a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">Ketamine</a></li>
<li>Mesulergine</li>
<li><a href="Modafinil.htm" tppabs="https://ptable.com/wiki/compounds/A/Modafinil" title="Modafinil">Modafinil</a></li>
<li>OSU-6162</li>
<li>Pardoprunox</li>
<li>PD-128,907</li>
<li>PD-168,077</li>
<li>PF-219,061</li>
<li>PF-592,379</li>
<li><a href="Phencyclidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phencyclidine" title="Phencyclidine">Phencyclidine</a></li>
<li>Piribedil</li>
<li>Pramipexole</li>
<li>Preclamol</li>
<li>Propylnorapomorphine</li>
<li>Pukateine</li>
<li>Quinagolide</li>
<li>Quinelorane</li>
<li>Quinpirole</li>
<li>RDS-127</li>
<li>Ro10-5824</li>
<li><a href="Ropinirole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li>Roxindole</li>
<li><a href="Salvinorin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Salvinorin_A" title="Salvinorin A">Salvinorin A</a></li>
<li>SKF-83,959</li>
<li>Sumanirole</li>
<li>Talipexole</li>
<li>Umespirone</li>
<li>WAY-100,635</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Typical antipsychotics</i>: <a href="Acepromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acepromazine" title="Acepromazine">Acepromazine</a></li>
<li><a href="Acetophenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetophenazine" title="Acetophenazine">Acetophenazine</a></li>
<li>Azaperone</li>
<li>Benperidol</li>
<li><a href="Bromperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromperidol" title="Bromperidol">Bromperidol</a></li>
<li>Butaclamol</li>
<li>Butaperazine</li>
<li><span class="new">Chloracizine</span></li>
<li>Chlorproethazine</li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chlorprothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorprothixene" title="Chlorprothixene">Chlorprothixene</a></li>
<li>Ciclindole</li>
<li>Clopenthixol</li>
<li><span class="new">Clothixamide</span></li>
<li>Clopimozide</li>
<li><a href="Droperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Droperidol" title="Droperidol">Droperidol</a></li>
<li>Fluacizine</li>
<li>Fluanisone</li>
<li>Flucindole</li>
<li>Fluotracen</li>
<li><a href="Flupentixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Flupentixol" title="Flupentixol">Flupentixol (flupenthixol)</a> (+melitracen)</li>
<li><a href="Fluphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluphenazine" title="Fluphenazine">Fluphenazine</a></li>
<li><span class="new">Fluprothixene</span></li>
<li><a href="Fluspirilene.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluspirilene" title="Fluspirilene">Fluspirilene</a></li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li>Homopipramol</li>
<li>Lenperone</li>
<li><a href="Levomepromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levomepromazine" title="Levomepromazine">Levomepromazine (methotrimeprazine)</a></li>
<li><a href="Levosulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Levosulpiride" title="Levosulpiride">Levosulpiride</a></li>
<li><a href="Loxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loxapine" title="Loxapine">Loxapine</a></li>
<li><a href="Mesoridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesoridazine" title="Mesoridazine">Mesoridazine</a></li>
<li>Moperone</li>
<li>Naranol</li>
<li>Nemonapride</li>
<li><a href="Penfluridol.htm" tppabs="https://ptable.com/wiki/compounds/A/Penfluridol" title="Penfluridol">Penfluridol</a></li>
<li>Perathiepin</li>
<li>Perazine</li>
<li>Pericyazine (periciazine)</li>
<li><a href="Perphenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Perphenazine" title="Perphenazine">Perphenazine</a> (+amitriptyline)</li>
<li><span class="new">Piflutixol (pifluthixol)</span></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>Pipamperone</li>
<li>Preclamol</li>
<li><a href="Prochlorperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prochlorperazine" title="Prochlorperazine">Prochlorperazine</a></li>
<li><a href="Promazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promazine" title="Promazine">Promazine</a></li>
<li>Prothipendyl</li>
<li><a href="Spiperone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spiperone" title="Spiperone">Spiperone (spiroperidol)</a></li>
<li>Sulforidazine</li>
<li><a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">Sulpiride</a></li>
<li><a href="Sultopride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sultopride" title="Sultopride">Sultopride</a></li>
<li><span class="new">Teflutixol</span></li>
<li>Thiopropazate</li>
<li><a href="Thioproperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioproperazine" title="Thioproperazine">Thioproperazine</a></li>
<li><a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li>Timiperone</li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a> (+tranylcypromine)</li>
<li><a href="Triflupromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triflupromazine" title="Triflupromazine">Triflupromazine</a></li>
<li>Trifluperidol</li>
<li><span class="new">Zetidoline</span></li>
<li><a href="Zuclopenthixol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zuclopenthixol" title="Zuclopenthixol">Zuclopenthixol</a></li></ul>

<ul><li><i>Atypical antipsychotics</i>: <a href="Amisulpride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amisulpride" title="Amisulpride">Amisulpride</a></li>
<li>Asenapine</li>
<li>BL-1020</li>
<li>Blonanserin</li>
<li>Carpipramine</li>
<li><span class="new">Cinuperone</span></li>
<li>Clocapramine</li>
<li>Clorotepine</li>
<li>Clotiapine (clothiapine)</li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li>Cyamemazine</li>
<li>DHA-clozapine</li>
<li>Dixyrazine</li>
<li>Elopiprazole</li>
<li>Flumezapine</li>
<li>Fluperlapine</li>
<li>Gevotroline</li>
<li>Iloperidone</li>
<li>Lurasidone</li>
<li>Mazapertine</li>
<li>Melperone</li>
<li><a href="Molindone.htm" tppabs="https://ptable.com/wiki/compounds/A/Molindone" title="Molindone">Molindone</a></li>
<li>Mosapramine</li>
<li>Ocaperidone</li>
<li><a href="Olanzapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Olanzapine" title="Olanzapine">Olanzapine</a> (+fluoxetine)</li>
<li><a href="Paliperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Paliperidone" title="Paliperidone">Paliperidone</a></li>
<li>Perospirone</li>
<li>Piperacetazine</li>
<li><a href="Pipotiazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pipotiazine" title="Pipotiazine">Pipotiazine</a></li>
<li>Piquindone</li>
<li><a href="Quetiapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quetiapine" title="Quetiapine">Quetiapine</a></li>
<li><a href="Remoxipride.htm" tppabs="https://ptable.com/wiki/compounds/A/Remoxipride" title="Remoxipride">Remoxipride</a></li>
<li><a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">Risperidone</a></li>
<li><a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">Sertindole</a></li>
<li><span class="new">Tefludazine</span></li>
<li><span class="new">Tenilapine</span></li>
<li>Tiospirone</li>
<li>Veralipride</li>
<li>Zicronapine</li>
<li><a href="Ziprasidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ziprasidone" title="Ziprasidone">Ziprasidone</a></li>
<li>Zotepine</li></ul>

<ul><li><i>Antiemetics/gastroprokinetics/sedatives</i>: <a href="Aceprometazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aceprometazine" title="Aceprometazine">Aceprometazine</a></li>
<li>AS-8112</li>
<li><a href="Alimemazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alimemazine" title="Alimemazine">Alimemazine</a></li>
<li><a href="Alizapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Alizapride" title="Alizapride">Alizapride</a></li>
<li><a href="Benzquinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzquinamide" title="Benzquinamide">Benzquinamide</a></li>
<li>Bromopride</li>
<li>Clebopride</li>
<li><a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">Domperidone</a></li>
<li>Eticlopride</li>
<li><a href="Hydroxyzine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxyzine" title="Hydroxyzine">Hydroxyzine</a></li>
<li>Itopride</li>
<li><a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">Metoclopramide</a></li>
<li>Metopimazine</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Thiethylperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiethylperazine" title="Thiethylperazine">Thiethylperazine</a></li>
<li><a href="Trimethobenzamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethobenzamide" title="Trimethobenzamide">Trimethobenzamide</a></li></ul>

<ul><li><i>Antidepressants</i>: <a href="Amoxapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxapine" title="Amoxapine">Amoxapine</a></li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li>Opipramol</li>
<li><a href="Propiomazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Propiomazine" title="Propiomazine">Propiomazine</a></li>
<li><a href="Trimipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimipramine" title="Trimipramine">Trimipramine</a></li></ul>

<ul><li><i>Others</i>: 3-PPP</li>
<li><span class="new">Alpiropride</span></li>
<li>Azapride</li>
<li><a href="Buspirone.htm" tppabs="https://ptable.com/wiki/compounds/A/Buspirone" title="Buspirone">Buspirone</a></li>
<li>Desmethoxyfallypride</li>
<li><a href="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Ethoxycarbonyl-2-ethoxy-1%2C2-dihydroquinoline" title="N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline">EEDQ</a></li>
<li>F-15063</li>
<li>Fallypride</li>
<li>Fananserin</li>
<li><a href="Fenfluramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenfluramine" title="Fenfluramine">Fenfluramine</a></li>
<li>GSK-789,472</li>
<li>Iodobenzamide</li>
<li><span class="new">Isocorypalmine</span></li>
<li>L-741,626</li>
<li>L-745,870</li>
<li>Levofenfluramine</li>
<li><span class="new">LEK-8829</span></li>
<li><a href="Metergoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metergoline" title="Metergoline">Metergoline</a></li>
<li>Metitepine (methiothepin)</li>
<li>N-Methylspiperone</li>
<li>Nafadotride</li>
<li>Nuciferine</li>
<li>PNU-99,194</li>
<li>Pridopidine</li>
<li>Raclopride</li>
<li>Sarizotan</li>
<li>SB-277,011-A</li>
<li><span class="new">Seridopidine</span></li>
<li>Sonepiprazole</li>
<li>Spiroxatrine</li>
<li>Stepholidine</li>
<li><span class="new">SV-293</span></li>
<li><a href="Tetrahydropalmatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li>
<li><a href="Tiapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Tiapride" title="Tiapride">Tiapride</a></li>
<li>UH-232</li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><small><i><b>See also:</b> Receptor/signaling modulators</i></small></li>
<li><small><i>Adrenergics</i></small></li>
<li><small><i>Serotonergics</i></small></li>
<li><small><i>Monoamine reuptake inhibitors</i></small></li>
<li><small><i>Monoamine releasing agents</i></small></li>
<li><small><i>Monoamine metabolism modulators</i></small></li>
<li><small><i>Monoamine neurotoxins</i></small></li></ul>
</div></td></tr></tbody></table></div><span>
</span>













<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-12" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Modafinil&oldid=972422184  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Modafinil&oldid=972422184'" tppabs="https://en.wikipedia.org/wiki/?title=Modafinil&oldid=972422184">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>